DE102008036952A1 - Lightening material for keratin fibres, especially for bleaching human hair, comprises two separate components, one with hydrogen peroxide, plus an indicator which changes color when the components are mixed - Google Patents

Abstract

Lightening material (I) for keratin fibres, obtained by mixing (before use) two separately packaged preparations, one of which (A) contains hydrogen peroxide while the other (B) does not, in which at least one of the preparations (A) and (B) contains an indicator (II) which changes color when (A) and (B) are mixed together. An independent claim is included for a method for lightening (bleaching) keratin fibres by applying (I), leaving it to act for 5-60 minutes and then rinsing it off or washing it off with a shampoo.

Description

The The present invention relates to agents for brightening keratinischer Fibers made from two separately packaged preparations before use A) and B) are obtained by mixing, wherein the complete Mixing of the preparations by the color change of an indicator displayed in at least one of the preparations and a method of lightening keratinic fibers Use of these funds.

Changing the shape and color of the hair is an important area of modern cosmetics. This allows the hair's appearance to be adapted to current fashion trends as well as to the individual wishes of the individual. In this case, permanent wave and other hair-changing methods can be used almost independently of the type of hair to be treated. In contrast, dyeing and bleaching processes are limited to certain initial hair colors. The basics of the Blondierverfahren are known in the art and can be found in relevant monographs, eg. B. from Kh. Schrader, Basics and Formulations of Cosmetics, 2nd edition, 1989, Dr. med. Alfred Hüthig Verlag, Heidelberg , or W. Umbach (ed.), Cosmetics, 2nd edition, 1995, Georg Thieme Verlag, Stuttgart, New York , be read.

Next the coloring is the lightening of the own hair color resp. bleaching the very special desire of many consumers, since a blonde hair color considered attractive and desirable in terms of fashion becomes. For this purpose are in the market different Blondiermittel available with different bleaching performance. The oxidants contained in these products are able to by the oxidative destruction of the hair's own dye Melanin to lighten the hair fiber. For a moderate Bleaching effect is sufficient the use of hydrogen peroxide - if necessary using ammonia or other alkalizing agents - as Oxidizer alone, for achieving a stronger Bleaching effect is usually a mixture of hydrogen peroxide and peroxodisulfate salts and / or Peroxomonosulfatsalten.

at commercially available products for lightening or Bleaching of human hair is usually multi-component products, wherein the ready-to-use brightener by mixing the components produced immediately before use. For the production The brightening agents are preparations that are usually in solid, pasty or gel form (bleaching powder, Blondiercreme, Blondiergel), usually with diluted aqueous hydrogen peroxide solution (developer) mixed. This mixture is then applied to the hair and rinsed out again after a certain exposure time. The Duration of exposure to the hair to achieve a complete Brightening is between about 30 and 40 minutes.

Blondierprozesse on keratinic fibers usually run in alkaline pH values, in particular between 9.0 and 10.5. These pH values are necessary to an opening of the outer To ensure cuticle (cuticle) and a penetration the active species (dye precursors and / or hydrogen peroxide) to allow in the hair. As an alkalizing agent is usually Ammonia used.

There However, hydrogen peroxide in alkaline medium only partially stable is usually the aqueous hydrogen peroxide solution, which is also referred to as a developer, neutral to slightly acidic set. So that the ready-to-use lightening agent the desired alkaline pH, the second preparation, i. H. the Blondiergrundlage, z. B. the Blondierpulver, the Blondiercreme or the blonding gel, an alkalizing agent is added. In order to wise developers and Blondiergrundlage usually significantly different pH values.

to Achieving optimal application properties of the whitening products It is necessary that the preparations evenly before use and completely mixed.

There both developer and bleaching base usually as colorless or white formulations, it prepares the user Difficulties determining when a homogeneous mixture is present. There is therefore a risk that the brightener on the fibers is applied before the mixture is homogeneous. That means, that the mixture applied to the fibers is different Make the fibers a different composition, for example an increased proportion of oxidizing agent. This can lead to an uneven whitening result and / or a different degree of injury different areas of the treated fibers.

It Therefore, the object of this invention is means for whitening or Bleaching keratinous fibers that allow reliably determine if the preparations that make up the agents are prepared, are homogeneously mixed. this will achieved by the means according to the invention.

One The first object of the invention is therefore a means of lightening keratinic fibers, which before being used are packaged separately Preparations A) and B) is obtained by mixing, wherein preparation A) contains hydrogen peroxide and preparation B) free of Hydrogen peroxide, and wherein at least one of the preparations A) and B) contains at least one indicator which is used in the Mixing the preparations undergoes a color change.

Under keratin fibers or keratin fibers are furs, wool, To understand feathers and especially human hair. Although the agent according to the invention primarily for lightening are suitable for keratin fibers, is in principle a use also in other areas nothing contrary.

In usually it is sufficient and also preferred if only one of Preparations A) and B) at least one corresponding indicator contains. If the preparations are mixed, comes the Indicator in contact with the ingredients of the second preparation. The indicator is thus on the ingredients of the second preparation adjusted so that the indicator undergoes a color change on contact. Areas of mixture in which the first preparation containing the indicator contains, not yet in contact with the second preparation come easily recognized by the fact that here still no color change has taken place. Only when the whole mix is homogeneous, the color change of the indicator is completed.

preparation A) contains hydrogen peroxide. Preferably it is a usual developer, d. H. an aqueous one Hydrogen peroxide solution, optionally for Developer contains usual additives. As already mentioned above, these usually have a neutral to slightly acidic pH.

preparation B) is free of hydrogen peroxide. Preferably it is a common Blondiergrundlage, such as a Blondierpulver, a Blondiercreme or a Blondiergel. Particularly preferred is it is a cream or gel, with creams and gels being preferred which contain at least one alkalizing agent. Most notably they are preferably creams and gels which contain at least one Contain alkalizing agent and at least one nourishing substance. These preparations are usually adjusted strongly alkaline.

preparation A) and B) differ accordingly by the presence or absence of hydrogen peroxide and usually distinctly different pH-values.

When Indicators thus offer preferably redox indicators and pH indicators.

The Indicators are each preferably in an amount of 0.001 to 1 wt .-%, particularly preferably in an amount of 0.001 to 0.1 Wt .-% and particularly preferably in an amount of 0.001 to 0.05 % By weight, based in each case on the total agent used. Become used several indicators, the total amount to indicator preferably 0.001 to 2 wt .-%, more preferably 0.005 to 0.1 wt .-%, each based on the total agent.

According to one first preferred embodiment, the inventive Lightening agent obtained by mixing preparations A) and B), these having different pH values and one of the preparations contains a pH indicator.

preferred pH indicators are selected from α-naphtholphthalein, Thymol blue, p-xylenol blue, o-cresolphthalein, phenolphthalein and Thymolphthalein. These are each at a pH change from the neutral to weakly basic to strongly basic to a distinct one Color change on. Thus, α-naphtholphthalein shows in the pH range from 7.8 to 9.0 a color change from yellow to blue, phenolphthalein in the pH range 8.4 to 10.0, a color change from colorless to Purple and thymolphthalein in the pH range of 9.3 to 10.5 a Color change from colorless to blue.

Preferably these indicators are used in preparation A), d. H. the developer incorporated, wherein preparation A) preferably has a pH of 4 to 7.5. Preparation B) is basic, so that the addition of preparation B) to preparation A) to an increase the pH and thus a color change leads. Preferably Preparation B) has a pH of 8 to 14, more preferably from 10 to 14 and most preferably from 11 to 14.

According to one second preferred embodiment is used as an indicator a redox indicator used.

suitable Redox indicators are, for example, neutral red, methylene blue and Ferroin.

Methylene blue, a cationic dye, also known as Basic Blue 9 is known to be colorless in the oxidized state in the reduced state Condition blue. Is methylene blue in reduced form in the hydrogen peroxide-free Preparation B), this preparation is first colorless / white. By mixing with the hydrogen peroxide-containing Preparation A) leads to the oxidation of the methylene blue. A homogeneous one Mixing is indicated by the resulting mixture assumed a uniformly blue color Has. Neutral red, a cationic dye that is also found under the Designation Basic Red 5 is known, exhibits a color change from reduced to oxidized form from colorless to red, ferroin, a 1,10-phenanthroline-iron sulfate complex, from red to pale blue.

Preferably these indicators are used in preparation B), d. H. the Blondiergrundlage, incorporated. This is free of hydrogen peroxide. The redox indicator is in a reduced form and is by admixing the hydrogen peroxide-containing Preparation A) in the oxidized form.

Become it is not used exclusively redox indicators imperative that the preparations A) and B) different have pH values. Nevertheless, this is preferred. Preferably Therefore, in this case preparation A) has a pH of 4 to 7.5 and preparation B) has a pH of 8 to 14, particularly preferred from 10 to 14, and most preferably from 11 to 14.

Of course it is also possible a combination of pH indicators and redox indicators, again the above Indicators are preferred.

Preparation A) and thus also the ready-to-use brightening agent contains hydrogen peroxide. Preferably, hydrogen peroxide itself is used as the aqueous solution. Hydrogen peroxide can also be used in the form of a solid addition compound of hydrogen peroxide to inorganic or organic compounds such as sodium perborate, sodium percarbonate, magnesium percarbonate, sodium percarbamide, polyvinylpyrrolidone n H ₂ O ₂ (n is a positive integer greater than 0), urea peroxide and melamine peroxide , In the latter case, the addition compounds release hydrogen peroxide in the application mixture according to the invention, ie these agents contain, in addition to the addition compound in the cosmetic carrier, free hydrogen peroxide.

Very particular preference according to the invention is given to using the hydrogen peroxide as the aqueous hydrogen peroxide solution. The concentration of a hydrogen peroxide solution is determined on the one hand by the legal requirements and on the other hand by the desired effect; preferably 6 to 12 wt .-% solutions are used in water. Agents preferred according to the invention are characterized in that they contain, based on their total weight, from 0.01 to 12% by weight, preferably from 0.1 to 10% by weight, particularly preferably from 1 to 6% by weight, of hydrogen peroxide (calculated as 100 % H ₂ O ₂ ).

Blondierprozesse on keratin fibers usually run in an alkaline environment from. To the keratin fibers and also the skin as much as possible to spare, the setting of a too high pH value is not desirable. Therefore, it is preferable if the pH of the ready-to-use agent between 7 and 11, in particular between 8 and 10.5, and more preferably between 9 and 10.5 lies.

at The pH values for the purposes of the present invention are to pH values measured at a temperature of 22 ° C were.

The for adjusting the preferred pH of the brightening agent according to the invention usable alkalizing agent are, as already mentioned above, preferably in preparation B), and may be from the group that is formed from ammonia, alkali metal hydroxides, alkanolamines, alkali metal metasilicates, Alkali metal phosphates and alkali metal hydrogen phosphates selected become.

When Alkali metal ions are preferably lithium, sodium, potassium, in particular Sodium or potassium.

The usable as alkalizing agent according to the invention Alkali metal hydroxides are preferably selected from Group formed from sodium hydroxide and potassium hydroxide.

The alkanolamines which can be used as alkalizing agents according to the invention are preferably extracted selects from primary amines having a C ₂ -C ₆ -alkyl basic body which carries at least one hydroxyl group. Particularly preferred alkanolamines are selected from the group formed from 2-aminoethan-1-ol (monoethanolamine), 3-aminopropan-1-ol, 4-aminobutan-1-ol, 5-aminopentan-1-ol, 1 -Aminopropan-2-ol, 1-aminobutan-2-ol, 1-aminopentan-2-ol, 1-aminopentan-3-ol, 1-aminopentan-4-ol, 3-amino-2-methylpropan-1-ol , 1-amino-2-methylpropan-2-ol, 3-aminopropane-1,2-diol, 2-amino-2-methylpropane-1,3-diol. Very particularly preferred alkanolamines according to the invention are selected from the group consisting of 2-aminoethane-1-ol, 2-amino-2-methylpropan-1-ol and 2-amino-2-methylpropane-1,3-diol.

For the strong lightening of very dark hair is the sole use of hydrogen peroxide or its addition products to organic or inorganic compounds often insufficient. In these cases, a combination is usually made Hydrogen peroxide and persulfates or Peroxodisulfaten used.

Therefore the agent according to the invention can additionally at least one inorganic persulfate salt or peroxodisulfate salt contain.

preferred Peroxodisulfate salts are ammonium peroxodisulfate, potassium peroxodisulfate and sodium peroxodisulfate.

The Peroxodisulfate salts may be present in an amount of 0.1 to 25 Wt .-%, in particular in an amount of 0.5 to 15 wt .-%, based on the total weight of the ready-to-use agent be.

Of the Use of persulfate salts or peroxodisulfate salts takes place in usually in the form of an optionally dedusted powder or a molded body molded in shape. To be favoured the persulfates or peroxodisulfates as a separately packaged component C) provided.

The Formulations A) and B) can be used for developers or Blondiergrundlagen usual other ingredients contain.

Preferably the preparations A) and / or B) is an emulsifier or a surfactant added, with surface-active substances depending on the field of application as surfactants or as emulsifiers and from anionic, cationic, zwitterionic, amphoteric and nonionic surfactants and emulsifiers are selected. These substances will be below described in detail.

• – lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen (Seifen),
• – Ethercarbonsäuren der Formel RO(CH₂CH₂O)_xCH₂COOH, in der R eine lineare Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1 bis 16 ist,
• – Acylsarcoside mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acyltauride mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acylisethionate mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Sulfobernsteinsäuremono- und -dialkylester mit 8 bis 24 C-Atomen in der Alkylgruppe und Sulfobernsteinsäuremono-alkylpolyoxyethylester mit 8 bis 24 C-Atomen in der Alkylgruppe und 1 bis 6 Oxyethylgruppen,
• – lineare Alkansulfonate mit 8 bis 24 C-Atomen,
• – lineare α-Olefinsulfonate mit 8 bis 24 C-Atomen,
• – Sulfonate ungesättigter Fettsäuren mit 8 bis 24 C-Atomen und 1 bis 6 Doppelbindungen,
• – α-Sulfofettsäuremethylester von Fettsäuren mit 8 bis 30 C-Atomen,
• – Alkylsulfate und Alkylethersulfate der Formel RO(CH₂CH₂O)_xSO₃H, in der R eine bevorzugt lineare Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1 bis 12 ist,
• – Gemische oberflächenaktiver Hydroxysulfonate,
• – sulfatierte Hydroxyalkylpolyethylen- und/oder Hydroxyalkylenpropylenglykolether,
• – Ester der Weinsäure und Zitronensäure mit Alkoholen, die Anlagerungsprodukte von etwa 2-15 Molekülen Ethylenoxid und/oder Propylenoxid an Fettalkohole mit 8 bis 22 C-Atomen darstellen,
• – Alkyl- und/oder Alkenyletherphosphate der Formel
  
  in der R bevorzugt für einen aliphatischen, gegebenenfalls ungesättigten Kohlenwasserstoffrest mit 8 bis 30 Kohlenstoffatomen, R' für Wasserstoff, einen Rest (CH₂CH₂O)_yR und x und y unabhängig voneinander für eine Zahl von 1 bis 10 steht,
• – sulfatierte Fettsäurealkylenglykolester der Formel RC(O)O(alkO)_nSO₃H, in der R für einen linearen oder verzweigten, aliphatischen, gesättigten und/oder ungesättigten Alkylrest mit 6 bis 22 C-Atomen, alk für CH₂CH₂, CHCH₃CH₂ und/oder CH₂CHCH₃ und n für eine Zahl von 0,5 bis 5 steht,
• – Monoglyceridsulfate und Monoglyceridethersulfate der Formel (MGS)
  
  in der R für einen linearen oder verzweigten Alkylrest mit 6 bis 22 Kohlenstoffatomen, und x, y und z in Summe für 0 oder für Zahlen von 1 bis 30, vorzugsweise 2 bis 10 stehen. Typische Beispiele für im Sinne der Erfindung geeignete Monoglycerid(ether)sulfate sind die Umsetzungsprodukte von Laurinsäuremonoglycerid, Kokosfettsäuremonoglycerid, Palmitinsäuremonoglycerid, Stearinsäuremonoglycerid, Ölsäuremonoglycerid und Talgfettsäuremonoglycerid sowie deren Ethylenoxidaddukte mit Schwefeltrioxid oder Chlorsulfonsäure in Form ihrer Natriumsalze. Vorzugsweise werden Monoglyceridsulfate der Formel (MGS) eingesetzt, in der R für einen linearen Alkylrest mit 8 bis 18 Kohlenstoffatomen steht.

Suitable anionic surfactants in preparations according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group of about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule. Examples of suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group,

• - linear and branched fatty acids with 8 to 30 carbon atoms (soaps),
• Ether carboxylic acids of the formula RO (CH ₂ CH ₂ O) _x CH ₂ COOH, in which R is a linear alkyl group having 8 to 30 C atoms and x = 0 or 1 to 16,
• Acylsarcosides having 8 to 24 C atoms in the acyl group,
• Acyltaurides having 8 to 24 carbon atoms in the acyl group,
• Acyl isethionates having 8 to 24 C atoms in the acyl group,
• Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group and sulfosuccinic acid monoalkyl polyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups,
• - linear alkanesulfonates having 8 to 24 carbon atoms,
• Linear α-olefinsulfonates having 8 to 24 C atoms,
• Sulfonates of unsaturated fatty acids having 8 to 24 C atoms and 1 to 6 double bonds,
• Α-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms,
• Alkyl sulfates and alkyl ether sulfates of the formula RO (CH ₂ CH ₂ O) _x SO ₃ H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x = 0 or 1 to 12,
• Mixtures of hydroxysulfonates,
• Sulfated hydroxyalkylpolyethylene and / or hydroxyalkylene glycol ethers,
• Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols containing 8 to 22 carbon atoms,
• - Alkyl and / or alkenyl ether of the formula
  
  in which R is an aliphatic, optionally unsaturated hydrocarbon radical having 8 to 30 carbon atoms, R 'is hydrogen, a radical (CH ₂ CH ₂ O) _y R and x and y independently of one another have a number from 1 to 10,
• - sulfated Fettsäurealkylenglykolester of the formula RC (O) O (AlkO) _n SO ₃ H, in which R is a linear or branched, aliphatic, saturated and / or unsaturated alkyl radical having 6 to 22 carbon atoms, Alk is CH ₂ CH ₂ CHCH ₃ CH ₂ and / or CH ₂ CHCH ₃ and n is a number from 0.5 to 5,
• Monoglyceride sulfates and monoglyceride ether sulfates of the formula (MGS)
  
  in which R is a linear or branched alkyl radical having 6 to 22 carbon atoms, and x, y and z are in total 0 or numbers of 1 to 30, preferably 2 to 10. Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts. Preferably, monoglyceride sulfates of the formula (MGS) are used, in which R is a linear alkyl radical having 8 to 18 carbon atoms.

preferred Anionic surfactants are alkyl sulfates, alkyl ether sulfates and ether carboxylic acids with 10 to 18 C atoms in the alkyl group and up to 12 glycol ether groups in the molecule.

When zwitterionic surfactants become such surface active Compounds referred to in the molecule at least one quaternary ammonium group and at least one carboxylate, Sulfonate or sulfate group wear. Particularly suitable zwitterionic Surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinates, for example, the cocoalkyl dimethyl ammonium glycinate, N-acyl aminopropyl N, N-dimethyl ammonium glycinates, for example, the Kokosacylaminopropyl-dimethylammoniumglycinat, and 2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarboxymethylglycinat. A preferred zwitterionic surfactant is that under the INCI name Cocamidopropyl betaine known fatty acid amide derivative.

Amphoteric surfactants are understood to mean those surface-active compounds which, apart from a C ₈ -C ₂₄ -alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO ₃ H group and which are capable of forming internal salts , Examples of suitable amphoteric surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group. Particularly preferred amphoteric surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C ₁₂ -C ₁₈ acylsarcosine.

• – Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare und verzweigte Fettalkohole mit 8 bis 30 C-Atomen, an Fettsäuren mit 8 bis 30 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe,
• – mit einem Methyl- oder C₂-C₆-Alkylrest endgruppenverschlossene Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare und verzweigte Fettalkohole mit 8 bis 30 C-Atomen, an Fettsäuren mit 8 bis 30 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe, wie beispielsweise die unter den Verkaufsbezeichnungen Dehydol^® LS, Dehydol^® LT (Cognis) erhältlichen Typen,
• – C₁₂-C₃₀-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Glycerin,
• – Polyglycerinester und alkoxylierte Polyglycerinester, wie beispielsweise Poly(3)glycerindiisostearat (Handelsprodukt: Lameform^®TGI (Henkel)) und Poly(2)glycerinpolyhydroxystearat (Handelsprodukt: Dehymuls^®PGPH (Henkel)).
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,
• – Polyolfettsäureester, wie beispielsweise das Handelsprodukt Hydagen^® HSP (Cognis) oder Sovermol-Typen (Cognis),
• – alkoxylierte, bevorzugt propoxylierte und insbesondere ethoxylierte, Mono-, Di- und Triglyceride, wie beispielsweise Glycerinmonolaurat + 20 Ethylenoxid und Glycerinmonostearat + 20 Ethylenoxid,
• – alkoxylierte Fettsäurealkylester der Formel RC(O)-(OCH₂CH₂)_wOR', in der RC(O)- für einen linearen oder verzweigten, gesättigten und/oder ungesättigten Acylrest mit 6 bis 22 Kohlenstoffatomen, R' für lineare oder verzweigte Alkylreste mit 1 bis 4 Kohlenstoffatomen und w für Zahlen von 1 bis 20 steht,
• – Aminoxide,
• – Hydroxymischether,
• – Sorbitanfettsäureester und Anlagerungeprodukte von Ethylenoxid an Sorbitanfettsäureester wie beispielsweise die Polysorbate, Sorbitanmonolaurat und Sorbitanmonolaurat + 20 Mol Ethylenoxid (EO),
• – Zuckerfettsäureester und Anlagerungsprodukte von Ethylenoxid an Zuckerfettsäureester,
• – Anlagerungsprodukte von Ethylenoxid an Fettsäurealkanolamide und Fettamine,
• – Fettsäure-N-alkylglucamide,
• – Alkylphenole und Alkylphenolalkoxylate mit 6 bis 21, insbesondere 6 bis 15 Kohlenstoffatomen in der Alkylkette und 0 bis 30 Ethylenoxid- und/oder Propylenoxid-Einheiten. Bevorzugte Vertreter dieser Klasse sind beispielsweise Nonylphenol + 4 EO, Nonylphenol + 9 EO, Octylphenol + 3 EO und Octylphenol + 8 EO;
• – Alkylpolyglykoside entsprechend der allgemeinen Formel RO-(Z)_x, wobei R für Alkyl, Z für Zucker sowie x für die Anzahl der Zuckereinheiten steht. Die erfindungsgemäß verwendbaren Alkylpolyglykoside können lediglich einen bestimmten Alkylrest R enthalten. Üblicherweise werden diese Verbindungen aber ausgehend von natürlichen Fetten und Ölen oder Mineralölen hergestellt. In diesem Fall liegen als Alkylreste R Mischungen entsprechend den Ausgangsverbindungen bzw. entsprechend der jeweiligen Aufarbeitung dieser Verbindungen vor.

Furthermore, it has proved to be advantageous if the brightening agents according to the invention contain nonionic surfactants. Nonionic surfactants contain as hydrophilic group z. A polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether groups. Such compounds are, for example

• - Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 carbon atoms and to alkylphenols having 8 to 15 carbon atoms in the alkyl group,
• - with a methyl or C ₂ -C ₆ alkyl radical end-capped addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 C Atoms and alkylphenols having 8 to 15 C atoms in the alkyl group, such as those available under the trade names Dehydol ^® LS, LT Dehydol ^® types (Cognis),
• C ₁₂ -C ₃₀ -fatty acid mono- and diesters of addition products of 1 to 30 mol of ethylene oxide with glycerol,
• - polyglycerol esters and alkoxylated polyglycerol esters, such as poly (3) glycerol diisostearate (commercial product: Lameform ^® TGI (Henkel)) and poly (2) glycerinpolyhydroxystearat (commercial product: Dehymuls ^® PGPH (Henkel)).
• Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
• - polyol, such as the commercially available product ^® Hydagen HSP (Cognis) or Sovermol types (Cognis),
• Alkoxylated, preferably propoxylated and in particular ethoxylated, mono-, di- and triglycerides, such as glycerol monolaurate + 20 ethylene oxide and glycerol monostearate + 20 ethylene oxide,
• - alkoxylated fatty acid alkyl esters of the formula RC (O) - (OCH ₂ CH ₂ ) _w OR ', in which RC (O) - represents a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R' is linear or branched alkyl radicals having 1 to 4 carbon atoms and w is from 1 to 20,
• - amine oxides,
• - hydroxymix ether,
• Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates, sorbitan monolaurate and sorbitan monolaurate + 20 moles of ethylene oxide (EO),
• Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters,
• Adducts of ethylene oxide with fatty acid alkanolamides and fatty amines,
• Fatty acid N-alkylglucamides,
• - Alkylphenols and Alkylphenolalkoxylate having 6 to 21, in particular 6 to 15 carbon atoms in the alkyl chain and 0 to 30 ethylene oxide and / or propylene oxide units. Preferred representatives of this class are, for example, nonylphenol + 4 EO, nonylphenol + 9 EO, octylphenol + 3 EO and octylphenol + 8 EO;
• - alkyl polyglycosides corresponding to the general formula RO- (Z) _x, where R is alkyl, Z is glucose and x is the number of sugar units. The alkyl polyglycosides which can be used according to the invention can only contain one particular alkyl radical R. Usually, however, these compounds are prepared starting from natural fats and oils or mineral oils. In this case, the alkyl radicals R are mixtures corresponding to the starting compounds or corresponding to the particular work-up of these compounds.

Suitable nonionic surfactants are, in particular, C ₈ -C ₂₂ -alkyl mono- and oligoglycosides and their ethoxylated analogs. In particular, the nonethoxylated compounds have been found to be particularly suitable.

• – im Wesentlichen aus C₈- und C₁₀-Alkylgruppen,
• – im Wesentlichen aus C₁₂- und C₁₄-Alkylgruppen,
• – im Wesentlichen aus C₈- bis C₁₆-Alkylgruppen oder
• – im Wesentlichen aus C₁₂- bis C₁₆-Alkylgruppen oder
• – im Wesentlichen aus C₁₆ bis C₁₈-Alkylgruppen besteht.

Particularly preferred are those alkyl polyglycosides of the formula RO- (Z) _x , in which R

• Essentially C ₈ and C ₁₀ alkyl groups,
• Essentially of C ₁₂ and C ₁₄ alkyl groups,
• Essentially of C ₈ to C ₁₆ alkyl groups or
• Substantially from C ₁₂ to C ₁₆ alkyl groups or
• - Consists essentially of C ₁₆ to C ₁₈ alkyl groups.

These Compounds are characterized in that as sugar component Z any mono- or oligosaccharides can be used. Usually be sugars with 5 or 6 carbon atoms and the corresponding Used oligosaccharides. Such sugars are, for example, glucose, Fructose, galactose, arabinose, ribose, xylose, lyxose, allose, Altrose, mannose, gulose, idose, talose and sucrose. preferred Sugar building blocks are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.

The Alkylpolyglycosides which can be used according to the invention contain on average 1.1 to 5 sugar units. Alkylpolyglykoside with x values of 1.1 to 2.0 are preferred. Very particularly preferred are alkyl glycosides in which x is 1.1 to 1.8.

Also the alkoxylated homologs of said alkyl polyglycosides can used according to the invention. These homologs can average up to 10 ethylene oxide and / or Propylene oxide units per Alkylglykosideinheit included.

Further preferred nonionic surfactants are the alkylene oxide addition products of saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid. Preparations with excellent properties are also obtained when they are used as nonionic surfactants contain fatty acid esters of ethoxylated glycerol.

Especially preferred nonionic surfactants are because of the ease of processing substances that are commercially available as solids or liquids in pure form are. The definition of purity refers to this Not related to chemically pure compounds. Rather, especially when it comes to natural products is used, mixtures of different homologues, for example with different alkyl chain lengths, as with products Base of natural fats and oils are obtained. Even with alkoxylated products are usually mixtures different degrees of alkoxylation. The term purity refers in this context rather to the fact that the selected substances are preferably free of solvents, Adjusting agents and other accompanying substances should be.

at the surfactants, the adducts of ethylene and / or propylene oxide represent fatty alcohols or derivatives of these addition products, can both products with a "normal" homolog distribution as well as those with a narrow homolog distribution become. Under "normal" homolog distribution are mixtures understood by homologues who are involved in the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates as catalysts. Narrowed homolog distributions are obtained when, for example Hydrotalcites, alkaline earth metal salts of ether carboxylic acids, Alkaline earth metal oxides, hydroxides or alcoholates as catalysts be used. The use of products with narrow homolog distribution may be preferred.

The anionic, nonionic, zwitterionic or amphoteric surfactants are in amounts of 0.1 to 45 wt .-%, preferably 1 to 30 wt .-% and most preferably from 1 to 15 wt .-%, based on the Total amount of ready-to-use agent used.

According to the invention preferred are also cationic surfactants of the quaternary type Ammonium compounds, the esterquats and the amidoamines. preferred quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, Dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, z. Cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, Distearyldimethylammonium chloride, lauryldimethylammonium chloride, Lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, as well as those under the INCI names Quaternium-27 and Quaternium-83 known imidazolium compounds. The long alkyl chains of the above Surfactants preferably have 10 to 18 carbon atoms. Further cationic used according to the invention Surfactants are the quaternized protein hydrolysates.

The alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines and are characterized in addition to a good conditioning effect especially by their good biodegradability. An inventively particularly suitable compound from this group of substances under the name Tegoamid ^® S 18 commercial stearamidopropyl dimethylamine is.

Likewise very readily biodegradable are quaternary ester compounds, so-called "ester quats". Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element. Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines. Such products are marketed under the trade names Stepantex® ^{®, ®} and Dehyquart® Armocare® ^®. The products Armocare ^® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ^® F-75, Dehyquart ^® C-4046, Dehyquart ^® L80 and Dehyquart ^® AU-35 are examples of such esterquats.

The cationic surfactants are used in the invention Agents preferably in amounts of 0.05 to 10 wt .-%, based on the entire remedy, included. Amounts of 0.1 to 5 wt .-% are particularly preferred.

In In a preferred embodiment, non-ionic, zwitterionic and / or amphoteric surfactants and mixtures thereof be preferred.

• – Anlagerungsprodukte von 4 bis 30 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe,
• – C₁₂-C₂₂-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Polyole mit 3 bis 6 Kohlenstoffatomen, insbesondere an Glycerin,
• – Ethylenoxid- und Polyglycerin-Anlagerungsprodukte an Methylglucosid-Fettsäureester, Fettsäurealkanolamide und Fettsäureglucamide,
• – C8-C22-Alkylmono- und -oligoglycoside und deren ethoxylierte Analoga, wobei Oligomerisierungsgrade von 1,1 bis 5, insbesondere 1,2 bis 2,0, und Glucose als Zuckerkomponente bevorzugt sind,
• – Gemische aus Alkyl-(oligo)-glucosiden und Fettalkoholen zum Beispiel das im Handel erhältliche Produkt Montanov^® 68,
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,
• – Partialester von Polyolen mit 3 bis 6 Kohlenstoffatomen mit gesättigten Fettsäuren mit 8 bis 22 C-Atomen,
• – Sterine. Als Sterine wird eine Gruppe von Steroiden verstanden, die am C-Atom 3 des Steroid-Gerüstes eine Hydroxylgruppe tragen und sowohl aus tierischem Gewebe (Zoosterine) wie auch aus pflanzlichen Fetten (Phytosterine) isoliert werden. Beispiele für Zoosterine sind das Cholesterin und das Lanosterin. Beispiele geeigneter Phytosterine sind Ergosterin, Stigmasterin und Sitosterin. Auch aus Pilzen und Hefen werden Sterine, die sogenannten Mykosterine, isoliert.
• – Phospholipide. Hierunter werden vor allem die Glucose-Phospolipide, die z. B. als Lecithine bzw. Phosphatidylcholine aus z. B. Eidotter oder Pflanzensamen (z. B. Sojabohnen) gewonnen werden, verstanden.
• – Fettsäureester von Zuckern und Zuckeralkoholen, wie Sorbit
• – Polyglycerine und Polyglycerinderivate wie beispielsweise Polyglycerinpoly-12-hydroxystearat (Handelsprodukt Dehymuls^® PGPH)
• – Lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen und deren Na-, K-, Ammonium-, Ca-, Mg- und Zn- Salze.

Preparation A) and / or B) may also contain at least one emulsifier. Such emulsifiers are, for example

• Addition products of from 4 to 30 mol of ethylene oxide and / or from 0 to 5 mol of propylene oxide onto linear fatty alcohols having from 8 to 22 carbon atoms, to fatty acids containing from 12 to 22 carbon atoms and to alkylphenols having from 8 to 15 carbon atoms in the alkyl group,
• C ₁₂ -C ₂₂ -fatty acid mono- and diesters of addition products of from 1 to 30 mol of ethylene oxide onto polyols having from 3 to 6 carbon atoms, in particular to glycerol,
• Ethylene oxide and polyglycerol addition products to methyl glucoside fatty acid esters, fatty acid alkanolamides and fatty acid glucamides,
• C8-C22-alkylmono- and -oligoglycosides and their ethoxylated analogues, with degrees of oligomerization of from 1.1 to 5, in particular from 1.2 to 2.0, and glucose as sugar component being preferred,
• Glucosides mixtures of alkyl (oligo) and fatty alcohols, for example, the commercially available product ^® Montanov 68, -
• Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
• Partial esters of polyols having 3 to 6 carbon atoms with saturated fatty acids having 8 to 22 C atoms,
• - sterols. Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
• - Phospholipids. These include, above all, the glucose phospholipids, which are z. B. as lecithins or phosphatidylcholines from z. Egg yolks or plant seeds (eg soybeans) are understood.
• - fatty acid esters of sugars and sugar alcohols, such as sorbitol
• - polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ^® PGPH)
• - Linear and branched fatty acids with 8 to 30 carbon atoms and their Na, K, ammonium, Ca, Mg and Zn salts.

The agents according to the invention contain the emulsifiers preferably in amounts of 0.1 to 25 wt .-%, in particular 0.5 to 15% by weight, based on the total amount of ready-to-use agent.

The agents according to the invention can continue contain at least one nourishing substance. This may be in preparation A) and / or B). It is particularly preferred if at least preparation B) at least one nourishing substance (Care substance) contains.

A The first group of suitable care substances are protein hydrolysates and / or their derivatives.

protein are product mixtures that are acidic, basic or enzymatic catalyzed degradation of proteins (proteins) can be obtained. The term protein hydrolyzates according to the invention also Total hydrolyzates and individual amino acids and their derivatives as well as mixtures of different amino acids understood. Furthermore, according to the invention from amino acids and amino acid derivatives built-up polymers under the term Understood protein hydrolysates. The latter include, for example, polyalanine, Polyasparagin, Polyserin etc. count. Further examples for compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride. Of course can according to the invention also β-amino acids and their derivatives such as β-alanine, anthranilic acid or hippuric acid. The molecular weight of Protein hydrolysates which can be used according to the invention is between 75, the molecular weight of glycine, and 200,000, Preferably, the molecular weight is 75 to 50,000 and completely more preferably 75 to 20,000 daltons.

According to the invention Protein hydrolyzates both vegetable and animal or marine or synthetic origin.

Animal protein hydrolysates are, for example, elastin, collagen, Kerstin, silk and milk protein protein hydrolysates, which may also be in the form of salts. Such products are, for example, under the trademarks Dehylan ^® (Cognis), Promois® ^® (Interorgana) Collapuron ^® (Cognis), Nutrilan® ^® (Cognis), Gelita-Sol ^® (German Gelatinefabriken Stoess and Co), Lexein ^® (Inolex) sericin (Pentapharm) and kerasol tm ^® (Croda) sold.

Particularly interesting is the use of silk protein hydrolysates. By silk one understands the fibers of the cocoon of the mulberry silkworm (Bombyx mori L.). The raw silk fiber consists of a double thread fibroin. As a cement substance, sericin holds this double thread together. Silk consists of 70-80 wt .-% of fibroin, 19-28 wt .-% sericin, 0.5-1 wt .-% of fat and 0.5-1 wt .-% of dyes and mineral constituents.

The essential components of sericin are with about 46 wt .-% hydroxy amino acids. The sericin consists of a group of 5 to 6 proteins. The essential amino acids of sericin are serine (Ser, 37 Wt%), aspartate (Asp, 26 wt%), glycine (Gly, 17 wt%), alanine (As), leucine (Leu) and tyrosine (Tyr).

The water-insoluble fibroin is associated with scleroproteins to count long-chain molecular structure. The main ingredients of the fibroin are glycine (44% by weight), alanine (26% by weight), and tyrosine (13% by weight). Another essential structural feature of fibroin is the hexapeptide sequence Ser-Gly-Ala-Gly-Ala-Gly.

Technically, it is possible in a simple manner to separate the two silk proteins from each other. So it is not surprising that both sericin and fibroin are known as raw materials for use in cosmetic products each by itself. Furthermore, protein hydrolysates and derivatives based on the respective individual silk proteins are known raw materials in cosmetic products. For example, sericin as such is available from Pentapharm ltd. sold as a commercial product called Sericin Code 303-02. Far more often, fibroin is offered as a protein hydrolyzate with different molecular weights in the market. These hydrolyzates are sold especially as "silk hydroylates". Thus hydrolyzed fibroin is distributed with average molecular weights from 350 to 1000, for example, under the trade designation Promois ^® Silk.

The protein hydrolyzates of sericin and fibroin and the derivatives prepared therefrom can be obtained from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis. The hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons. Preference is given to those protein hydrolysates of sericin and fibroin and / or derivatives thereof, whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 10,000 daltons. Furthermore, cationic protein hydrolysates of sericin and fibroin also mean quaternized amino acids and mixtures thereof. The quaternization of the protein hydrolysates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides. Furthermore, the cationic protein hydrolysates may also be further derivatized. As typical examples of the cationic protein hydrolysates and derivatives which can be used according to the invention, those mentioned under the INCI names in US Pat "International Cosmetic Ingredient Dictionary and Handbook," (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, suite 300, Washington, DC 20036-4702) Cocodimonium Hydroxypropyl Hydrolyzed Silk, Cocodimonium Hydroxypropyl Silk Amino Acids, Hydroxypropyltrimonium Hydrolyzed Silk, Lauryldimonium Hydroxypropyl Hydrolyzed Silk, Steardimonium Hydroxypropyl Hydrolyzed Silk, Quaternium-79 Hydrolyzed Silk. As typical examples of the anionic protein hydrolysates and derivatives according to the invention are those under the INCI names in "International Cosmetic Ingredient Dictionary and Handbook," (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, suite 300, Washington, DC 20036-4702) and commercially available products mentioned: Potassium Cocoyl Hydrolyzed Silk, Sodium Lauroyl Hydrolyzed Silk or Sodium Stearoyl Hydrolyzed Silk. Finally, typical examples of the derivatives of sericin and fibroin which can be used according to the invention are the products available commercially under the INCI names: Ethyl Ester of Hydrolyzed Silk and Hydrolyzed Silk PG-Propyl Methylsilanediol. Also useful in the present invention, although not necessarily preferred, are the commercially available products having the INCI names Palmitoyl Oligopeptide, Palmitoyl Pentapeptide-3, Palmitoyl Pentapeptide-2, Acetyl Hexapeptide-1, Acetyl Hexapeptide-3, Copper Tripeptide-1, Hexapeptide-1 , Hexapeptide-2, MEA-Hydrolyzed Silk.

Protein hydrolysates of vegetable origin, eg. As soybean, almond, pea, potato and wheat protein hydrolysates are, for example, under the trademarks Gluadin ^® (Cognis), DiaMin ^® (Diamalt), Lexein ^® (Inolex), Hydrosoy ^® (Croda), Hydrolupin ^® (Croda) , hydro Sesame ^® (Croda), Hydro tritium ^® (Croda) and Crotein ^® (Croda) available.

Although the use of the protein hydrolysates is preferred as such, amino acid mixtures otherwise obtained may be used in their place, if appropriate. Also possible is the use of derivatives of protein hydrolysates, for example in the form of their fatty acid condensation products. Such products are marketed for example under the names Lamepon ^® (Cognis), Lexein ^® (Inolex), Crolastin ^® (Croda), Crosilk ^® (Croda) or Crotein ^® (Croda).

Of course The teaching of the invention includes all isomers Forms such as cis-trans isomers, diastereomers and chiral isomers.

According to the invention It is also possible to use a mixture of several protein hydrolysates use.

The Protein hydrolysates are in the inventive For example, in concentrations of 0.01 wt .-% up to 20 wt .-%, preferably from 0.05 wt .-% up to 15 wt .-% and completely more preferably in amounts of from 0.05% to 5% by weight, respectively based on the entire application preparation included.

In a particular embodiment contains the inventive Agent as protein hydrolyzate a Kertainhydrolysat, being a Kertainhydrolysat with a molecular weight of 2 to 6 kDa, preferably of 3 to 4 kDa, determined by size exclusion HPLC, is preferred.

The Agent contains the Kertainhydrolysat preferably in one Amount of 0.01 to 1 wt .-%, particularly preferably from 0.02 to 0.8 Wt .-%, each based on the total agent.

A Another group of suitable care substances are the silicones, preferably Silicone oils and / or silicone gums.

suitable Silicone oils or silicone gums are especially dialkyl and alkylaryl siloxanes such as dimethylpolysiloxane and Methylphenylpolysiloxan, and their alkoxylated, quaternized or anionic derivatives. Preference is given to cyclic and linear Polydialkylsiloxanes, their alkoxylated and / or aminated derivatives, Dihydroxypolydimethylsiloxanes and polyphenylalkylsiloxanes.

Silicone oils cause a wide variety of effects. For example, at the same time they influence the dry and wet combability, the grip of dry and wet hair and the shine. The term silicone oils is understood by the person skilled in the art as meaning several structures of silicon-organic compounds. Initially, these are understood to mean the dimethiconols (S1). These may be both linear and branched as well as cyclic or cyclic and branched. Linear dimethiconols can be represented by the following structural formula (S1-I): (HOSiR ¹ ₂ ) -O- (SiR ² ₂ -O-) _x (SiR ¹ ₂ OH) (S1-I)

Branched dimethiconols can be represented by the structural formula (S1-II):

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ₂ to C ₃₀ linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. Non-limiting examples of the groups represented by R ¹ and R ² include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; Preferably R ¹ and R ^{2 is} an alkyl radical containing from 1 to about 6 carbon atoms, most preferably R ¹ and R ^{2 are} methyl. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of the dimethiconols are between 1000 D and 10,000,000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ° C. with the aid of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970. Preferred viscosities are between 1,000 and 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.

Examples of such products include the following commercial products: Botanisil NU-150M (Botanigenics), Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, Ultrapure Dimethiconol (Ultra Chemical), Unisil SF-R (Universal Preserve), X-21-5619 ( Shin-Etsu Chemical Co.), Abil OSW 5 (Degussa Care Specialties), ACC DL-9430 Emulsion (Taylor Chemical Company), AEC Dimethiconol & Sodium Dodecylbenzenesulfonate (A & E Connock (Perfumery & Cosmetics) Ltd.), BC Dimethiconol Emulsion 95 (Basildon Chemical Company, Ltd.), Cosmetic Fluid 1401, Cosmetic Fluid 1403, Cosmetic Fluid 1501, Cosmetic Fluid 1401 DC (all aforementioned Chemsil Silicones, Inc.), Dow Corning 1401 Fluid, Dow Corning 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 HVF Emulsion, Dow Corning 9546 Silicone Elastomer Blend (all aforementioned Dow Corning Corporation), Dub Gel SI 1400 (Stearinerie Dubois Fils), HVM 4852 Emulsion (Crompton Corporation), Jeesilc 6056 (Jeen International Corporation), Lubrasil , Lubrasil DS (both Guardian Laboratories), Nonychosine E, Nonychosine V (both exsymol), SanSurf Petrolatum-25, Satin Finish (both Collaborative Laboratories, Inc.), Silatex-D30 (Cosmetic Ingredient Resources), Silsoft 148, Silsoft E-50, Silsoft E-623 (all aforementioned Crompton Corporation), SM555, SM2725, SM2765, SM2785 (all aforementioned GE Silicones), Taylor T-Sil CD-1, Taylor TME-4050E (all Taylor Chemical Company), TH V 148 (Crompton Corporation), Tixogel CYD-1429 (Sud-Chemie Wacker-Belsil CM 5090, Wacker-Belsil DM 3096, Wacker-Belsil DM 3112 VP, Wacker-Belsil DM 8005 VP, Wacker-Belsil DM 60081 VP (all. Performance Additives), Wacker-Belsil CM 1000, Wacker-Belsil previously mentioned Wacker-Chemie GmbH).

Dimethicones (S2) form the second group of silicones which may be present according to the invention. These may be both linear and branched as well as cyclic or cyclic and branched. Linear dimethicones can be represented by the following structural formula (S2-I): (SiR ¹ ₃ ) -O- (SiR ¹ R ² -O-) _x - (SiR ¹ ₃ ) (S2-I)

Branched dimethicones can be represented by the structural formula (S2-II):

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ₂ to C ₃₀ linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. Non-limiting examples of the groups represented by R ¹ and R ² include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; Preferably, R ¹ and R ^{2 is} an alkyl radical containing from 1 to about 6 carbon atoms, and more preferably R ¹ and R ^{2 are} methyl. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of the dimethicones are between 1000 D and 10,000,000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ° C. with the aid of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970. Preferred viscosities are between 1,000 and 5,000,000 cPs, particularly preferred viscosities are between 10,000 and 3,000,000 cps. Most preferably, the viscosity is in the range between 50,000 and 200,000 cps.

dimethicone (S3) form another group of silicones that are suitable.

Dimethicone copolyols can be represented by the following structural formulas: (SiR ¹ ₃ ) -O- (SiR ² ₂ -O-) _x - (SiR ² PE-O-) _y - (SiR ¹ ₃ ) (S3-I), PE- (SiR ¹ ₂ ) -O- (SiR ² ₂ -O-) _x - (SiR ¹ ₂ ) -PE (S3-II)

Branched dimethicone copolyols can be represented by the structural formula (S3-III):

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ₂ to C ₃₀ linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. Non-limiting examples of the groups represented by R ¹ and R ² include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; Preferably R ¹ and R ^{2 is} an alkyl radical containing from 1 to about 6 carbon atoms, most preferably R ¹ and R ^{2 are} methyl. PE stands for a polyoxyalkylene radical. Preferred polyoxyalkylene radicals are derived from ethylene oxide, propylene oxide and glycerol. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of the dimethicones are between 1000 D and 10,000,000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ° C. with the aid of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970. Preferred viscosities are between 1,000 and 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.

Corresponding dimethicone copolyols are commercially available and are sold, for example, by Dow Corning under the name Dow ^Corning® 5330 Fluid.

Of course, the teaching according to the invention also encompasses the fact that the dimethiconols, dimethicones and / or dimethicone copolymers can already be present as an emulsion. In this case, the corresponding emulsion of dimethiconols, dimethicones and / or dimethicone copolyols can be prepared both after the preparation of the corresponding dimethiconols, dimethicones and / or dimethicone copolyols from these and the conventional methods of emulsification known to the person skilled in the art. For this purpose, both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions. Of course, the emulsions of dimethiconols, dimethicones and / or dimethicone copolyols can also be prepared directly by an emulsion polymerization process. Such methods are also well known to the person skilled in the art. For example, refer to the Encyclopedia of Polymer Science and Engineering, Volume 15, Second Edition, pages 204 to 308, John Wiley & Sons, Inc. 1989 , This reference is expressly incorporated by reference.

If the dimethiconols, dimethicones and / or dimethicone copolyols as Emulsion, then the droplet size is the emulsified particles according to the invention 0.01 to 10000 microns, preferably 0.01 to 100 microns, especially preferably 0.01 to 20 microns and most preferably 0.01 up to 10 μm. The particle size is thereby determined by the method of light scattering.

If branched dimethiconols, dimethicones and / or dimethicone copolyols are used, it is to be understood that the branching is greater than a random branching, which occurs randomly due to impurities of the respective monomers. For the purposes of the present invention, branched dimethiconols, dimethicones and / or dimethicone copolyols are therefore to be understood as meaning that the branching agent degree is greater than 0.01%. Preferably, a degree of branching is greater than 0.1%, and most preferably greater than 0.5%. The degree of branching is determined from the ratio of the unbranched monomers to the branching monomers, that is, the amount of tri- and tetrafunctional siloxanes. According to the invention, both low-branched and highly branched dimethiconols, dimethicones and / or dimethicone copolyols can be very particularly preferred.

suitable Silicones are also amino-functional silicones (S4), in particular the silicones, which are grouped under the INCI name Amodimethicone are. These are silicones which have at least one, optionally substituted, amino group.

Such silicones may, for. By the formula (S4-I) M (R a Q b SiO (4-ab) / 2) ) x (R c SiO (4-c) / 2) ) y M (S4-I) wherein R in the above formula is a hydrocarbon or a hydrocarbon group having from 1 to about 6 carbon atoms, Q is a polar group of the general formula -R ¹ Z wherein R ^{1 is} a divalent linking group attached to hydrogen and Z is an organic, amino-functional radical containing at least one amino-functional group, carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms; "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 1 to about 3, "a" + "b" is less than or equal to 3, and "c" is a number in the range from about 1 to about 3, and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number ranging from about 20 to about 10,000 , preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy. Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CH ₂ ) ₃ C (O) OCH ₂ CH ₂ -, - C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -.

Z is an organic, amino-functional radical containing at least one functional amino group. A possible formula for Z is NH (CH ₂ ) _z NH ₂ , where z is an integer from 1 to 50. Another possible formula for Z is -NH (CH ₂ ) _z NH (CH ₂ ) _zz , in which both z and zz independently of one another represent an integer from 1 to 50, this structure comprising diamino ring structures, such as piperazinyl. Z is particularly preferably a -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for Z is -N (CH ₂ ) _z NX ¹ X ² or -NX ¹ X ² , wherein each of X ¹ and X ² is independently selected from hydrogen and a hydrocarbon radical having from 1 to about 6 carbon atoms.

Most preferably, Q is a polar, amine-functional radical of the formula -CH ₂ CH ₂ CH ₂ NHCH ₂ CH ₂ NH ₂ .

The molar ratio of the R _a Q _b SiO _{(4-ab) / 2} units to the R _c SiO _{(4-c) / 2} units is in the range of about 1: 2 to 1:65, preferably about 1: 5 to about 1:65, and more preferably from about 1:15 to about 1:20. When one or more silicones of the above formula are used, the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend.

• – G ist -H, eine Phenylgruppe, -OH, -O-CH₃, -CH₃, -CH₂CH₃, -CH₂CH₂CH₃, -CH(CH₃)₂, -CH₂CH₂CH₂CH₃, -CH₂CH(CH₃)₂, -CH(CH₃)CH₂CH₃, -C(CH₃)₃;
• – a steht für eine Zahl zwischen 0 und 3, insbesondere 0;
• – b steht für eine Zahl zwischen 0 und 1, insbesondere 1,
• – m und n sind Zahlen, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt,
• – R' ist ein monovalenter Rest ausgewählt aus
• – -N(R'')-CH₂-CH₂-N(R'')₂
• – -N(R'')₂
• – -N⁺(R'')₃A^–
• – -N⁺H(R'')₂A^–
• – -N⁺H₂(R'')A^–
• – -N(R'')-CH₂-CH₂-N⁺R''H₂A^–,

wobei jedes R'' für gleiche oder verschiedene Reste aus der Gruppe -H, -Phenyl, -Benzyl, der C_1-20-Alkylreste, vorzugsweise -CH₃, -CH₂CH₃, -CH₂CH₂CH₃, -CH(CH₃)₂, -CH₂CH₂CH₂CH₃, -CH₂CH(CH₃)₂, -CH(CH₃)CH₂CH₃, -C(CH₃)₃, steht und A^– ein Anion repräsentiert, welches vorzugsweise ausgewählt ist aus Chlorid, Bromid, Iodid oder Methosulfat.Preferred amino-functional silicones correspond to the formula (S4-II) R _'a G _3-a -Si (OSiG _{2) n} - (OSiG _b R' _{2-b) m} -O-SiG _3-a -R _'a (S4-II), where:

• G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ ) ₃ ;
• A is a number between 0 and 3, in particular 0;
• B is a number between 0 and 1, in particular 1,
• M and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,
• - R 'is a monovalent radical selected from
• --N (R '') - CH ₂ -CH ₂ -N (R '') ₂
• - N (R '') ₂
• - N ⁺ (R '') ₃ A ^-
• - N ⁺ H (R '') ₂ A ^-
• - N ⁺ H ₂ (R '') A ^-
• --N (R '') - CH ₂ -CH ₂ -N ⁺ R''H ₂ A ^- ,

where each R "is identical or different radicals from the group -H, -phenyl, -benzyl, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , - CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ ) ₃ , and A ^- represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.

worin m und n Zahlen sind, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Particularly preferred amino-functional silicones correspond to the formula (S4-III)

wherein m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.

These Silicones are classified as trimethylsilylamodimethicones according to the INCI declaration designated.

worin R für -OH, -O-CH₃ oder eine -CH₃-Gruppe steht und m, n1 und n2 Zahlen sind, deren Summe (m + n1 + n2) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei die Summe (n1 + n2) vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Particular preference is furthermore given to amino-functional silicones of the formula (S4-IV)

wherein R is -OH, -O-CH ₃ or a -CH ₃ group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150, wherein the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.

These silicones are referred to as amodimethicone according to the INCI nomenclature and are available for example in the form of an emulsion as a commercial product Dow Corning ^® 949 in a mixture with a cationic and a nonionic surfactant.

Preferably Such amino-functional silicones are used which have an amine number above 0.25 meq / g, preferably above 0.3 meq / g and especially preferably above 0.4 meq / g. The amine number stands for the milliequivalents of amine per Grams of amino-functional silicone. It can be done by titration determined and also in the unit mg KOH / g.

• – oligomere Polydimethylcyclosiloxane (INCI-Bezeichnung: Cyclomethicone), insbesondere die tetramere und die pentamere Verbindung, die als Handelsprodukte DC 245 Fluid, DC 344 bzw. DC 345 von Dow Corning vertrieben werden,
• – Hexamethyl-Disiloxan (INCI-Bezeichnung: Hexamethyldisiloxane), z. B. das unter der Bezeichnung Abil^® K 520 vertriebenen Produkt,
• – Polyphenylmethylsiloxane (INCI-Bezeichnung: Phenyl Trimethicone), z. B. das Handelsprodukt DC 556 Cosmetic Grade Fluid von Dow Corning,
• – Ester sowie Partialester der Silikon-Glykol-Copolymere, wie sie beispielsweise von der Firma Fanning unter der Handelsbezeichnung Fancorsil^® LIM (INCI-Bezeichnung: Dimethicone Copolyol Meadowfoamate) vertrieben werden,
• – anionische Silikonöle, wie beispielsweise das Produkt Dow Corning^®1784.

Other suitable silicones are, for example

• Oligomeric polydimethylcyclosiloxanes (INCI name: cyclomethicone), in particular the tetrameric and pentameric compounds sold as commercial products DC 245 Fluid, DC 344 and DC 345, respectively, by Dow Corning,
• Hexamethyldisiloxane (INCI name: hexamethyldisiloxane), eg. B. the product sold under the name Abil ^® K 520,
• - Polyphenylmethylsiloxane (INCI name: Phenyl Trimethicone), z. For example, the commercial product DC 556 Cosmetic Grade Fluid from Dow Corning,
• - esters and partial esters of the silicone-glycol copolymers, such as, for example, by the company Fanning under the trade name LIM Fancorsil ^® (INCI name: dimethicone copolyol Meadowfoamate) to be expelled,
• Anionic silicone oils such as the Dow ^Corning® 1784 product.

According to a preferred embodiment, the agent according to the invention comprises at least two different silicone derivatives, more preferably a combination of a volatile and a nonvolatile silicone. Volatile silicones are understood as meaning those silicones which have a volatility which is equal to or greater than the volatility of the cyclic, pentameric dimethylsiloxane. Such combinations are also available as commercial products (eg, Dow ^Corning® 1401, Dow ^Corning® 1403, and Dow ^Corning® 1501, each containing mixtures of a cyclomethicone and a dimethiconol).

preferred Mixtures of different silicones are, for example, dimethicones and dimethiconols, linear dimethicones and cyclic dimethiconols. A most preferred mixture of silicones consists of at least one cyclic dimethiconol and / or dimethicone, at least another non-cyclic dimethicone and / or dimethiconol and at least one amino-functional silicone.

Become different silicones used as a mixture, so is the mixing ratio largely variable. However, all are preferably used for the mixture Silicones in a ratio of 5: 1 to 1: 5 in the case of a binary mixture used. A ratio of 3: 1 to 1: 3 is particularly preferred. Very particularly preferred mixtures contain all the silicones contained in the mixture as much as possible in a ratio of about 1: 1, in each case based on the amounts used in wt .-%.

The Means contain the silicones preferably in amounts of 1-25 Wt .-%, particularly preferably from 5-20 wt .-% and in particular preferably from 7-15% by weight, based on the total agent.

A Another group of care substances are the cationic surfactants, the already described above. These compounds come accordingly both the function of a surfactant, as well as the function of a care substance to.

A Another group of suitable care substances are nourishing polymers.

A first group of caring polymers are the cationic polymers. Cationic polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be "temporary" or "permanent" cationic. According to the invention, "permanently cationic" refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups. In particular, those polymers in which the quaternary ammonium group is bonded via a C _1-4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.

One particularly suitable homopolymer is, if desired crosslinked, poly (methacryloyloxyethyltrimethylammoniumchlorid) with the INCI name Polyquaternium-37. The crosslinking can, if desired with the help of multiply olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, Diallyl ethers, polyallyl polyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, Mannitol, sorbitol, sucrose or glucose. methylenebisacrylamide is a preferred crosslinking agent.

The homopolymer is preferably used in the form of a non-aqueous polymer dispersion which should not have a polymer content of less than 30% by weight. Such polymer dispersions are (under the names Salcare ^® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ^® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol (with a mixture of caprylic and capric acid INCI name: propylene glycol Dicaprylate / Dicaprate) and Tridecylpolyoxypropylen polyoxyethylene ether (INCI name : PPG-1-trideceth-6)) are commercially available.

• – quaternisierte Cellulose-Derivate, wie sie unter den Bezeichnungen Celquat^® und Polymer JR^® im Handel erhältlich sind. Die Verbindungen Celquat^® H 100, Celquat^® L 200 und Polymer JR^®400 sind bevorzugte quaternierte Cellulose-Derivate,
• – kationische Alkylpolyglycoside gemäß der DE-PS 44 13 686 ,
• – kationiserter Honig, beispielsweise das Handelsprodukt Honeyquat^® 50,
• – kationische Guar-Derivate, wie insbesondere die unter den Handelsnamen Cosmedia^®Guar und Jaguar^® vertriebenen Produkte,
• – Polysiloxane mit quartären Gruppen, wie beispielsweise die im Handel erhältlichen Produkte Q2-7224 (Hersteller: Dow Corning; ein stabilisiertes Trimethylsilylamodimethicon), Dow Corning^® 929 Emulsion (enthaltend ein hydroxyl-amino-modifiziertes Silikon, das auch als Amodimethicone bezeichnet wird), SM-2059 (Hersteller: General Electric), SLM-55067 (Hersteller: Wacker) sowie Abil^®-Quat 3270 und 3272 (Hersteller: Th. Goldschmidt), diquaternäre Polydimethylsiloxane, Quaternium-80),
• – polymere Dimethyldiallylammoniumsalze und deren Copolymere mit Estern und Amiden von Acrylsäure und Methacrylsäure. Die unter den Bezeichnungen Merquat^®100 (Poly(dimethyldiallylammoniumchlorid)) und Merquat^®550 (Dimethyldiallylammoniumchlorid-Acrylamid-Copolymer) im Handel erhältlichen Produkte sind Beispiele für solche kationischen Polymere,
• – Copolymere des Vinylpyrrolidons mit quaternierten Derivaten des Dialkylaminoalkylacrylats und -methacrylats, wie beispielsweise mit Diethylsulfat quaternierte Vinylpyrrolidon-Dimethylaminoethylmethacrylat-Copolymere. Solche Verbindungen sind unter den Bezeichnungen Gafquat^®734 und Gafquat^®755 im Handel erhältlich,
• – Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymere, wie sie unter den Bezeichnungen Luviquat^® FC 370, FC 550, FC 905 und HM 552 angeboten werden,
• – quaternierter Polyvinylalkohol,
• – sowie die unter den Bezeichnungen Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 und Polyquaternium 27 bekannten Polymeren mit quartären Stickstoffatomen in der Polymerhauptkette.

Further preferred cationic polymers are, for example

• - Quaternized cellulose derivatives, such as those under the names Celquat ^® and Polymer JR ^® commercially available. The compounds Celquat ^® H 100, Celquat L 200 and Polymer JR ^{® ®} 400 are preferred quaternized cellulose derivatives
• Cationic alkyl polyglycosides according to DE-PS 44 13 686 .
• - cationized honey, for example the commercial product Honeyquat ^® 50,
• - cationic guar derivatives, such as in particular the products sold under the trade names Cosmedia® ^® Guar and Jaguar ^®,
• Quaternary group polysiloxanes, such as the commercially available products Q2-7224 (manufactured by Dow Corning, a stabilized trimethylsilylamodimethicone), Dow ^Corning® 929 emulsion (containing a hydroxylamino-modified silicone, also referred to as amodimethicones), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ^® quat 3270 and 3272 (manufacturer: Th Goldschmidt.), diquaternary polydimethylsiloxanes, quaternium-80)
• - Dimethyldiallylammoniumsalze polymeric and their copolymers with esters and amides of acrylic acid and methacrylic acid. Under the names Merquat ^® 100 (Poly (dimethyldiallylammonium chloride)) and Merquat ^® 550 (dimethyldiallylammonium chloride-acrylamide copolymer) are examples of such cationic polymers,
• - Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers. Such compounds are sold under the names Gafquat ^® 734 and Gafquat ^® 755 commercially,
• - vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ^® FC 370, FC 550, FC 905 and HM 552,
• - quaternized polyvinyl alcohol,
• - as well as the polymers known under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 with quaternary nitrogen atoms in the polymer main chain.

Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ^® LM 200), known polymers. , Gaffix ^® VC 713 (manufactured by ISP): Also according to the invention can be used the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ^® ASCP 1011, Gafquat ^® HS 110, Luviquat ^® 8155 and Luviquat ^® MS 370 available are.

Further cationic polymers which can be used according to the invention are the so-called "temporary cationic" polymers. These polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic. For example, chitosan and its derivatives are preferred as designations for example under the trade Hydagen® ^® CMF, Hydagen® ^® HCMF, Kytamer ^® PC and Chitolam ^® NB / 101 are freely available commercially.

According to the invention is preferably used cationic polymers are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer ^® JR 400, Hydagen ^® HCMF and Kytamer ^® PC, cationic guar derivatives, cationic honey derivatives, in particular the commercial product Honeyquat ^® 50, cationic Alkyl polyglycodides according to the DE-PS 44 13 686 and polyquaternium-37 type polymers.

Furthermore, cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or Kerstin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates. The protein hydrolyzates on which the cationic derivatives according to the invention are based can be obtained from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis. The hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons. Furthermore, cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof. The quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides. Furthermore, the cationic protein hydrolysates may also be further derivatized. As typical examples of the cationic protein hydrolyzates and derivatives according to the invention, those mentioned under the INCI names in "International Cosmetic Ingredient Dictionary and Handbook," (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, suite 300, Washington, DC 20036-4702) Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hy droxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCI, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiolin Protein, Hydroxypropyltrimonium Hydrolyzed Keratin, Hydroxypropyltrimonium Hydrolyzed Rice Bran Protein, Hydroxypropyl Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein / Siloxysilicate, Laurdimonium Hydroxypropyl Hydrolyzed Soy Protein, Laurdimonium Hydroxypropyl Hydrolyzed Wheat Protein Lauridimonium Hydroxypropyl Hydrolyzed Wheat Protein / Siloxysilicate, Lauryldimonium Hyd Roxypropyl Hydrolyzed Casein, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Kerstin, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardimonium Hydroxypropyl Hydrolyzed Wheat Protein, Steartrimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Kerstin, Quaternium-79 Hydrolyzed Milk Protein, Quaternium-79 Hydrolyzed Soy Protein, Quaternium-79 Hydrolyzed Wheat protein.

All particularly preferred are the cationic protein hydrolysates and Derivatives on a vegetable basis.

• (a) Monomeren mit quartären Ammoniumgruppen der allgemeinen Formel (II), R¹-CH=CR²-CO-Z-(C_nH_2n)-N⁽⁺⁾R³R⁴R⁵ A^(–) (II)in der R¹ und R² unabhängig voneinander stehen für Wasserstoff oder eine Methylgruppe und R³, R⁴ und R⁵ jeweils unabhängig voneinander für eine Alkylgruppe mit 1 bis 4 Kohlenstoffatomen, Z eine NH-Gruppe oder ein Sauerstoffatom, n eine ganze Zahl von 2 bis 5 und das Anion einer organischen oder anorganischen Säure ist, und
• (b) monomeren Carbonsäuren der allgemeinen Formel (III), R⁶-CH=CR⁷-COOH (III)in denen R⁶ und R⁷ unabhängig voneinander für Wasserstoff oder eine Methylgruppe stehen.

Another group of caring polymers are the amphoteric polymers. Preferably used amphoteric polymers are those polymers which are composed essentially

• (a) monomers having quaternary ammonium groups of the general formula (II), R ¹ -CH = CR ² -CO-Z- (C _n H _2n ) -N ⁽⁺⁾ R ³ R ⁴ R ⁵ A ^(-) (II) in which R ¹ and R ² independently of one another are hydrogen or a methyl group and R ³ , R ⁴ and R ^{5 are} each independently an alkyl group having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer of 2 to 5 and the anion is an organic or inorganic acid, and
• (b) monomeric carboxylic acids of the general formula (III), R ⁶ -CH = CR ⁷ -COOH (III) in which R ⁶ and R ⁷ independently of one another represent hydrogen or a methyl group.

These compounds can be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention. With regard to the details of the preparation of these polymers is expressly based on the content of German patent application 39 29 973 Referenced. Very particular preference is given to those polymers in which monomers of the type (a) are used in which R ³ , R ⁴ and R ^{5 are} methyl groups, Z is an NH group and A ^{(-) is} a halide, methoxysulfate or ethoxysulfate Ion is; Acrylamidopropyltrimethylammonium chloride is a particularly preferred monomer (a). Acrylic acid is preferably used as monomer (b) for the stated polymers.

Of the Content of nourishing, cationic and / or amphoteric polymers is preferably 0.01 to 5 wt .-%, in particular 0.1 to 2 wt .-%, each based on the total application preparation.

When Nursing agent may continue to use the agent according to the invention at least one vitamin, one pro-vitamin, one vitamin precursor and / or one of these derivatives.

there are according to the invention such vitamins, pro-vitamins and vitamin precursors, usually the groups A, B, C, E, F and H are assigned.

The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The β-carotene is the pro-vitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The remedies contain the vitamin A component preferably in amounts of 0.05-1 wt .-%, based on the total application preparation.

• – Vitamin B₁ (Thiamin)
• – Vitamin B₂ (Riboflavin)
• – Vitamin B₃. Unter dieser Bezeichnung werden häufig die Verbindungen Nicotinsäure und Nicotinsäureamid (Niacinamid) geführt. Erfindungsgemäß bevorzugt ist das Nicotinsäureamid, das in den erfindungsgemäßen Mitteln bevorzugt in Mengen von 0,05 bis 1 Gew.-%, bezogen auf die gesamte Anwendungszubereitung, enthalten ist.
• – Vitamin B₅ (Pantothensäure, Panthenol und Pantolacton). Im Rahmen dieser Gruppe wird bevorzugt das Panthenol und/oder Pantolacton eingesetzt. Erfindungsgemäß einsetzbare Derivate des Panthenols sind insbesondere die Ester und Ether des Panthenols sowie kationisch derivatisierte Panthenole. Einzelne Vertreter sind beispielsweise das Panthenoltriacetat, der Panthenolmonoethylether und dessen Monoacetat sowie die in der WO 92/13829 offenbarten kationischen Panthenolderivate. Die genannten Verbindungen des Vitamin B₅-Typs sind in den erfindungsgemäßen Mitteln bevorzugt in Mengen von 0,05–10 Gew.-%, bezogen auf die gesamte Anwendungszubereitung, enthalten. Mengen von 0,1–5 Gew.-% sind besonders bevorzugt.
• – Vitamin B₆ (Pyridoxin sowie Pyridoxamin und Pyridoxal). Die genannten Verbindungen des Vitamin B₆-Typs sind in den erfindungsgemäßen Mitteln bevorzugt in Mengen von 0,01–5 Gew.-%, bezogen auf die gesamte Anwendungszubereitung, enthalten. Mengen von 0,05–1 Gew.-% sind besonders bevorzugt.

The vitamin B group or the vitamin B complex include, among others

• - Vitamin B ₁ (thiamine)
• - Vitamin B ₂ (riboflavin)
• - Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide, which is preferably contained in the agents according to the invention in amounts of from 0.05 to 1% by weight, based on the total application preparation.
• - Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are for example the Panthenoltriacetat, the Panthenolmonoethylether and its monoacetate as well as in the WO 92/13829 disclosed cationic panthenol derivatives. The said compounds of the vitamin B ₅ type are preferably contained in the agents according to the invention in amounts of 0.05-10% by weight, based on the total application preparation. Amounts of 0.1-5 wt .-% are particularly preferred.
• - Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal). The compounds of the vitamin B ₆ type mentioned are preferably contained in the agents according to the invention in amounts of 0.01-5% by weight, based on the total application preparation. Amounts of 0.05-1 wt .-% are particularly preferred.

vitamin C (ascorbic acid). Vitamin C is used in the invention Agents preferably in amounts of 0.1 to 3 wt .-%, based on the entire application preparation used. The use in form of palmitic acid ester, which may be glucosides or phosphates be preferred. The use in combination with tocopherols can also be preferred.

vitamin E (tocopherols, especially α-tocopherol). tocopherol and its derivatives, including in particular the esters such as the acetate, nicotinate, phosphate and succinate are in the agents according to the invention preferably in amounts from 0.05-1% by weight, based on the total application preparation, contain.

vitamin F. The term "vitamin F" usually becomes essential Fatty acids, especially linoleic acid, linolenic acid and arachidonic acid, understood.

vitamin H. As vitamin H, the compound becomes (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] imidazole-4-valeric acid but for the meantime the trivial name Biotin has prevailed. Biotin is in the invention Agents preferably in amounts of 0.0001 to 1.0 wt .-%, in particular in amounts of 0.001 to 0.01 wt .-%, each based on the total Application preparation included.

Prefers the agents according to the invention contain vitamins, Pro-vitamins and vitamin precursors from groups A, B, C, E and H.

panthenol, Pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.

All D-panthenol, if appropriate, is particularly preferred as a care substance in combination with at least one of the above-mentioned silicone derivatives used.

When Care material can the invention Means further contain at least one plant extract.

Usually These extracts are produced by extraction of the whole plant. However, it may also be preferred in individual cases, the Extracts of flowers and / or leaves only to produce the plant.

Regarding the inventively preferred plant extracts particular attention is drawn to the extracts mentioned in the page 44 of the 3rd edition of the guideline for the ingredient declaration of cosmetic Medium, published by the Industrieverband Körperpflege- and detergent e. V. (IKW), Frankfurt, beginning table are.

According to the invention especially the extracts of green tea, oak bark, stinging nettle, Witch hazel, hops, henna, chamomile, burdock root, horsetail, Hawthorn, lime blossom, almond, aloe vera, spruce needle, Horse chestnut, sandalwood, juniper, coconut, mango, apricot, Lime, Wheat, Kiwi, Melon, Orange, Grapefruit, Sage, Rosemary, Birch, Mallow, Meadowfoam, Quendel, Yarrow, Thyme, Melissa, Toadstool, coltsfoot, marshmallow, meristem, ginseng and ginger root prefers.

Especially preferred are the extracts of green tea, oak bark, Stinging nettle, witch hazel, hops, chamomile, burdock root, horsetail, Lime blossom, almond, aloe vera, coconut, mango, apricot, lime, Wheat, kiwi, melon, orange, grapefruit, sage, rosemary, birch, Meadowfoam, Quendel, Yarrow, Hauhechel, Meristem, Ginseng and ginger root.

All particularly suitable are the extracts of green tea, almond, Aloe vera, coconut, mango, apricot, lime, wheat, kiwi and Melon.

When Extraction agent for the preparation of said plant extracts may be used water, alcohols and mixtures thereof become. Among the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as the sole extractant also in mixture with water, preferred. Plant extracts based of water / propylene glycol in the ratio 1:10 to 10: 1 proved to be particularly suitable.

The Plant extracts can according to the invention both be used in pure as well as in diluted form. If used in diluted form, contain they usually about 2-80 wt .-% of active substance and as a solvent used in their extraction Extracting agent or extractant mixture.

Farther it may be preferred in the inventive Mixtures of several, especially two, different Use plant extracts.

When Nursing material is also suitable for a range of carboxylic acids.

Advantageous In the context of the invention, in particular short-chain Be carboxylic acids. Under short-chain carboxylic acids and their derivatives within the meaning of the invention are carboxylic acids which is saturated or unsaturated and / or straight-chain or branched or cyclic and / or aromatic and / or may be heterocyclic and a molecular weight smaller than 750. Preferred for the purposes of the invention saturated or unsaturated straight chain or branched carboxylic acids with one chain length from 1 to 16 carbon atoms in the chain, most preferably are those with a chain length of 1 to 12 carbon atoms in the chain.

The short-chain carboxylic acids according to the invention may have one, two, three or more carboxy groups. Preferred within the meaning of the invention are carboxylic acids having a plurality of carboxy groups, in particular di- and tricarboxylic acids. The carboxy groups may be wholly or partly present as esters, acid anhydride, lactone, amide, imidic acid, lactam, lactim, dicarboximide, carbohydrazide, hydrazone, hydroxam, hydroxime, amidine, amidoxime, nitrile, phosphonic or phosphate ester. The carboxylic acids which can be used according to the invention may of course be substituted along the carbon chain or the ring skeleton. The substituents of the carboxylic acids which can be used according to the invention include, for example, C ₁ -C ₈ -alkyl, C ₂ -C ₈ -alkenyl, aryl, aralkyl and aralkenyl, hydroxymethyl, C ₂ -C ₈ -hydroxyalkyl, C ₂ -C ₈ hydroxyalkenyl, aminomethyl, C ₂ -C ₈ aminoalkyl, cyano, formyl, oxo, thioxo, hydroxy, mercapto, amino, carboxy or imino groups. Preferred substituents are C ₁ -C ₈ alkyl, hydroxymethyl, hydroxy, amino and carboxy groups. Particularly preferred are substituents in α-position. Very particularly preferred substituents are hydroxy, alkoxy and amino groups, where the amino function may optionally be further substituted by alkyl, aryl, aralkyl and / or alkenyl radicals. Furthermore, preferred carboxylic acid derivatives are the phosphonic and phosphate esters.

in der Z steht für eine lineare oder verzweigte Alkyl- oder Alkenylgruppe mit 4 bis 12 Kohlenstoffatomen, n für eine Zahl von 4 bis 12 sowie eine der beiden Gruppen X und Y für eine COOH-Gruppe und die andere für Wasserstoff oder einen Methyl- oder Ethylrest, Dicarbonsäuren der allgemeinen Formel (N-I), die zusätzlich noch 1 bis 3 Methyl- oder Ethylsubstituenten am Cyclohexenring tragen sowie Dicarbonsäuren, die aus den Dicarbonsäuren gemäß Formel (N-I) formal durch Anlagerung eines Moleküls Wasser an die Doppelbindung im Cyclohexenring entstehen.Examples of carboxylic acids which can be used according to the invention include formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, oxalic acid, malonic acid, succinic acid, glutaric acid, glyceric acid, glyoxylic acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, propiolic acid, crotonic acid, Isocrotonic acid, elaidic acid, maleic acid, fumaric acid, muconic acid, citraconic acid, mesaconic acid, camphoric acid, benzoic acid, o, m, p-phthalic acid, naphthoic acid, toluoic acid, hydratropic acid, atropic acid, cinnamic acid, isonicotinic acid, nicotinic acid, bicarbamic acid, 4,4'-dicyano-6 , 6'-binicotinic acid, 8-carbamoyloctanoic acid, 1,2,4-pentanetricarboxylic acid, 2-pyrrole carboxylic acid, 1,2,4,6,7-naphthalene pentaacetic acid, malonaldehyde acid, 4-hydroxyphthalamic acid, 1-pyrazolecarboxylic acid, gallic acid or propane tricarboxylic acid, a dicarboxylic acid selected from the group consisting of compounds of general formula (NI),

in the Z is a linear or branched alkyl or alkenyl group having 4 to 12 carbon atoms, n is a number from 4 to 12 and one of the two groups X and Y is a COOH group and the other is hydrogen or a methyl or Ethyl radical, dicarboxylic acids of the general formula (NI), which additionally carry 1 to 3 methyl or ethyl substituents on the cyclohexene ring and dicarboxylic acids formed formally from the dicarboxylic acids according to formula (NI) by addition of a molecule of water to the double bond in the cyclohexene ring.

Dicarboxylic acids of the formula (NI) are known in the literature. This is for example US-A 3,753,968 to take a manufacturing process.

The Dicarboxylic acids of the formula (N-I) can be, for example by reaction of polyunsaturated dicarboxylic acids with unsaturated monocarboxylic acids in the form of a Diels-Alder cyclization are prepared. Usually one becomes of a polyunsaturated fatty acid go out as dicarboxylic acid component. Preferably, the accessible from natural fats and oils Linoleic acid. As monocarboxylic acid component in particular acrylic acid, but also z. For example, methacrylic acid and crotonic acid are preferred. Usually arise in reactions according to Diels-Alder isomer mixtures, in which a Component is present in excess. These isomer mixtures can according to the invention as well as the pure compounds are used.

Usable according to the invention in addition to the preferred dicarboxylic acids according to the formula (N-I) are also those dicarboxylic acids that are different from the Compounds according to formula (N-I) by 1 to 3 Differentiate methyl or ethyl substituents on the cyclohexyl ring or from these compounds formally by addition of a molecule Water are formed on the double bond of the cyclohexene ring.

The dicarboxylic acid (mixture), which is obtained by reacting linoleic acid with acrylic acid, has proved to be particularly effective according to the invention. It is a mixture of 5- and 6-carboxy-4-hexyl-2-cyclohexene-1-octanoic acid. Such compounds are commercially available under the designations Westvaco Diacid 1550 Westvaco Diacid ^{® ®} 1595 (manufacturer: Westvaco).

Next the short-chain carboxylic acids previously exemplified even their physiologically compatible Salts are used according to the invention. Examples for such salts are the alkali, alkaline earth and zinc salts, and ammonium salts, among which in the context of the present application also the mono-, di- and trimethyl, -ethyl and -hydroxyethyl ammonium salts to be understood. Especially preferred may be in the frame of the invention, however, with alkaline-reacting amino acids, such as arginine, lysine, ornithine and histidine Acids are used. Furthermore, it may be for formulation reasons be preferred, the carboxylic acid from the water-soluble Representatives, in particular the water-soluble salts.

Furthermore, it is inventively preferred to use 2-pyrrolidinone-5-carboxylic acid and derivatives thereof as the carboxylic acid. Particularly preferred are the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion in addition to hydrogen carries one to three C ₁ - to C ₄ alkyl groups. The sodium salt is most preferred. The amounts used in the products according to the invention are preferably 0.05 to 10 wt .-%, based on the total application preparation, particularly preferably 0.1 to 5 wt .-%, and particularly preferably 0.1 to 3 wt .-%.

Furthermore, it is preferred according to the invention to use hydroxycarboxylic acids and here again in particular the dihydroxy, trihydroxy and polyhydroxycarboxylic acids as well as the dihydroxy, trihydroxy and polyhydroxy di-, tri- and polycarboxylic acids. It has been shown that in addition to the hydroxycarbon acids and the hydroxycarboxylic acid esters and the mixtures of hydroxycarboxylic acids and their esters as well as polymeric hydroxycarboxylic acids and their esters can be very particularly preferred. Preferred hydroxycarboxylic acid esters are, for example, full esters of glycolic acid, lactic acid, malic acid, tartaric acid or citric acid. Further basically suitable hydroxycarboxylic esters are esters of β-hydroxypropionic acid, tartronic acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid. As the alcohol component of these esters are primary, linear or branched aliphatic alcohols having 8-22 C atoms, ie, for. As fatty alcohols or synthetic fatty alcohols. The esters of C ₁₂ -C ₁₅ fatty alcohols are particularly preferred. Esters of this type are commercially available, e.g. B. under the trademark Cosmacol ^® from EniChem Augusta Industriale. Particularly preferred polyhydroxypolycarboxylic acids are polylactic acid and polyuric acid and their esters.

When The care substance is still suitable for ectoin or ectoine derivatives, allantoin, Taurine and / or bisabolol.

und/oder deren physiologisch verträglichen Salze und/oder isomere oder stereoisomere Form verstanden, wobei
R¹⁰ steht für ein Wasserstoffatom, einen verzweigten oder unverzweigten C₁-C₄-Alkylrest oder einen C₂–C₄-Hydroxyalkylrest,
R¹¹ steht für ein Wasserstoffatom, eine Gruppierung -COOR¹⁴ oder eine Gruppierung -CO(NH)R¹⁴, wobei R¹⁴ für ein Wasserstoffatom, einen C₁-C₄-Alkylrest, einen Aminosäurerest, einen Dipeptid- oder einen Tripeptidrest stehen kann,
R¹² und R¹³ stehen unabhängig voneinander für ein Wasserstoffatom, einen C₁-C₄-Alkylrest oder eine Hydroxygruppe mit der Maßgabe, dass nicht beide Reste gleichzeitig für eine Hydroxygruppe stehen dürfen, und
n steht für eine ganze Zahl von 1 bis 3.According to the invention, under the terms "ectoine and ectoine derivatives", compounds of the formula (IV)

and / or their physiologically acceptable salts and / or isomeric or stereoisomeric form, wherein
R ¹⁰ represents a hydrogen atom, a branched or unbranched C ₁ -C ₄ -alkyl radical or a C ₂ -C ₄ -hydroxyalkyl radical,
R ¹¹ represents a hydrogen atom, a grouping -COOR ¹⁴ or a grouping -CO (NH) R ¹⁴ , where R ^{14 may be} a hydrogen atom, a C ₁ -C ₄ -alkyl radical, an amino acid radical, a dipeptide or a tripeptide radical .
R ¹² and R ¹³ independently of one another represent a hydrogen atom, a C ₁ -C ₄ -alkyl radical or a hydroxy group, with the proviso that both radicals may not simultaneously be a hydroxy group, and
n stands for an integer from 1 to 3.

Suitable physiologically tolerable salts of the general compounds of the formula (IVa) or (IVb) are, for example, the alkali metal, alkaline earth metal, ammonium, triethylamine or tris (2-hydroxyethyl) amine salts and those resulting from the reaction of compounds according to the formula (IVa) or (IVb) with inorganic and organic acids such as hydrochloric acid, phosphoric acid, sulfuric acid, branched or unbranched, substituted or unsubstituted (for example by one or more hydroxy groups) C ₁ -C ₄ mono- or dicarboxylic acids, aromatic carboxylic acids and sulfonic acids such as acetic acid, citric acid, benzoic acid, maleic acid, fumaric acid, tartaric acid and p-toluenesulfonic acid. Examples of particularly preferred physiologically acceptable salts are the Na, K, Mg and Ca and ammonium salts of the compounds of the formula (IVa) or (IVb), and the salts which are obtained by reacting compounds of the formula (IVa ) or (IVb) with hydrochloric acid, acetic acid, citric acid and benzoic acid.

Under isomeric or stereoisomeric forms of the compounds of the formula (IVa) or (IVb) are inventively all occurring optical isomers, diastereomers, racemates, zwitterions, cations or Mixtures thereof understood.

The term amino acid, the stereoisomeric forms, eg. As D and L forms, the following compounds:
Asparagine, arginine, aspartic acid, glutamine, glutamic acid, β-alanine, γ-aminobutyrate, N _ε -acetyllysine, N _δ -acetylornitin, N _γ -acetyldiaminobutyrate, N _α -acetyldiaminobutyrate, histidine, isoleucine,
Leucine, methionine, phenylalanine, serine, threonine and tyrosine.

L-amino acids are preferred. Amino acid residues are derived from the corresponding amino acids. The following amino acid residues are preferred:
Gly, Ala, Ser, Thr, Val, β-Ala, γ-aminobutyrate, Asp, Glu, Asn, Aln, N _ε -Acetyllysin, N _δ -Acetylornithin, N _γ -Acetyldiaminobutyrat, N _α -Acetyldiaminobutyrat.

The Short notation of the amino acids was carried out according to the commonly used Notation. The di- or tripeptide residues are in their chemical Nature after acid amides and disintegrate during hydrolysis in 2 or 3 amino acids. The amino acids in the di- or tripeptide residue are linked together by amide bonds.

Examples of C ₁ -C ₄ -alkyl groups in the compounds of the formula (IV) are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl and tert-butyl. Preferred alkyl groups are methyl and ethyl, methyl is a particularly preferred alkyl group. Preferred C ₂ -C ₄ -hydroxyalkyl groups are the groups 2-hydroxyethyl, 3-hydroxypropyl or 4-hydroxybutyl; 2-hydroxyethyl is a particularly preferred hydroxyalkyl group.

The agents according to the invention contain these care substances preferably in amounts of 0.001 to 2, in particular from 0.01 to 0.5 Wt .-%, each based on the total application preparation.

Also Saccharides can be used as a care substance in the inventive Funds are used.

It Both monosaccharides and oligosaccharides, such as cane sugar, lactose and raffinose used become. The use of monosaccharides is preferred according to the invention. Among the monosaccharides, in turn, such compounds are preferred containing 5 or 6 carbon atoms.

suitable Pentoses and hexoses are, for example, ribose, arabinose, xylose, Lyxose, allose, altrose, glucose, mannose, gulose, idose, galactose, Talose, fucose and fructose. Arabinose, glucose, galactose and fructose are preferably used carbohydrates. Very particularly preferred Glucose is used in both the D - (+) or L - (-) configuration or is suitable as a racemate.

Farther can also derivatives of these pentoses and hexoses, like the corresponding on- and uronic acids (sugar acids), Sugar alcohols and glycosides, used according to the invention become. Preferred sugars are gluconic acid, Glucuronic acid, sugar acidity, mannosaccharic acid and the mucic acid. Preferred sugar alcohols are sorbitol, Mannitol and Dulcite. Preferred glycosides are the methylglucosides.

There the mono- or oligosaccharides used usually extracted from natural resources such as starch usually they have the corresponding commodities Configurations (eg D-glucose, D-fructose and D-galactose).

The Mono- or oligosaccharides are in the inventive Hair treatment agents preferably in an amount of 0.1 to 8 wt .-%, particularly preferably 1 to 5% by weight, based on the total application preparation, contain.

The Agent may further contain at least one lipid as a conditioner.

Lipids suitable according to the invention are phospholipids, for example soya lecithin, egg lecithin and cephalins, and also the substances known under the INCI names linoleic amidopropyl PG-dimonium chlorides phosphates, cocamidopropyl PG-dimonium chlorides phosphates and stearamidopropyl PG-dimonium chlorides phosphates. These are sold, for example, by the company Mona under the trade names Phospholipid ^EFA® , Phospholipid ^PTC® and Phospholipid ^SV® .

The agents according to the invention contain the lipids preferably in amounts of 0.01-10 wt .-%, in particular 0.1-5 Wt .-%, based on the total application preparation.

Farther are suitable as a care substance oil body.

• – pflanzliche Öle. Beispiele für solche Öle sind Sonnenblumenöl, Olivenöl, Sojaöl, Rapsöl, Mandelöl, Jojobaöl, Orangenöl, Weizenkeimöl, Pfirsichkernöl und die flüssigen Anteile des Kokosöls. Geeignet sind aber auch andere Triglyceridöle wie die flüssigen Anteile des Rindertalgs sowie synthetische Triglyceridöle.
• – flüssige Paraffinöle, Isoparaffinöle und synthetische Kohlenwasserstoffe sowie Di-n-alkylether mit insgesamt zwischen 12 bis 36 C-Atomen, insbesondere 12 bis 24 C-Atomen, wie beispielsweise Di-n-octylether, Di-n-decylether, Di-n-nonylether, Di-n-undecylether, Di-n-dodecylether, n-Hexyl-n-octylether, n-Octyl-n-decylether, n-Decyl-n-undecylether, n-Undecyl-n-dodecylether und n-Hexyl-n-Undecylether sowie Di-tert-butylether, Di-iso-pentylether, Di-3-ethyldecylether, tert.-Butyl-n-octylether, iso-Pentyl-n-octylether und 2-Methyl-pentyl-n-octylether. Die als Handelsprodukte erhältlichen Verbindungen 1,3-Di-(2-ethyl-hexyl)-cyclohexan (Cetiol^® S) und Di-n-octylether (Cetiol^® OE) können bevorzugt sein.
• – Esteröle. Unter Esterölen sind zu verstehen die Ester von C₆-C₃₀-Fettsäuren mit C₂-C₃₀-Fettalkoholen. Bevorzugt sind die Monoester der Fettsäuren mit Alkoholen mit 2 bis 24 C-Atomen. Beispiele für eingesetzte Fettsäurenanteile in den Estern sind Capronsäure, Caprylsäure, 2-Ethylhexansäure, Caprinsäure, Laurinsäure, Isotridecansäure, Myristinsäure, Palmitinsäure, Palmitoleinsäure, Stearinsäure, Isostearinsäure, Ölsäure, Elaidinsäure, Petroselinsäure, Linolsäure, Linolensäure, Elaeostearinsäure, Arachinsäure, Gadoleinsäure, Behensäure und Erucasäure sowie deren technische Mischungen, die z. B. bei der Druckspaltung von natürlichen Fetten und Ölen, bei der Oxidation von Aldehyden aus der Roelen'schen Oxosynthese oder der Dimerisierung von ungesättigten Fettsäuren anfallen. Beispiele für die Fettalkoholanteile in den Esterölen sind Isopropylalkohol, Capronalkohol, Caprylalkohol, 2-Ethylhexylalkohol, Caprinalkohol, Laurylalkohol, Isotridecylalkohol, Myristylalkohol, Cetylalkohol, Palmoleylalkohol, Stearylalkohol, Isostearylalkohol, Oleylalkohol, Elaidylalkohol, Petroselinylalkohol, Linolylalkohol, Linolenylalkohol, Elaeostearylalkohol, Arachylalkohol, Gadoleylalkohol, Behenylalkohol, Erucylalkohol und Brassidylalkohol sowie deren technische Mischungen, die z. B. bei der Hochdruckhydrierung von technischen Methylestern auf Basis von Fetten und Ölen oder Aldehyden aus der Roelen'schen Oxosynthese sowie als Monomerfraktion bei der Dimerisierung von ungesättigten Fettalkoholen anfallen. Erfindungsgemäß besonders bevorzugt sind Isopropylmyristat (Rilanit^® IPM), Isononansäure-C16-18-alkylester (Cetiol^® SN), 2-Ethylhexylpalmitat (Cegesoft^® 24), Stearinsäure-2-ethylhexylester (Cetiol^® 868), Cetyloleat, Glycerintricaprylat, Kokosfettalkoholcaprinat/-caprylat (Cetiol^® LC), n-Butylstearat, Oleylerucat (Cetiol^® J 600), Isopropylpalmitat (Rilanit^® IPP), Oleyl Oleate (Cetiol^®), Laurinsäurehexylester (Cetiol^® A), Di-n-butyladipat (Cetiol^® B), Myristylmyristat (Cetiol^® MM), Cetearyl Isononanoate (Cetiol^® SN), Ölsäuredecylester (Cetiol^® V).
• – Dicarbonsäureester wie Di-n-butyladipat, Di-(2-ethylhexyl)-adipat, Di-(2-ethylhexyl)-succinat und Di-isotridecylacelaat sowie Diolester wie Ethylenglykol-dioleat, Ethylenglykol-di-isotridecanoat, Propylenglykol-di(2-ethylhexanoat), Propylenglykol-di-isostearat, Propylenglykol-di-pelargonat, Butandiol-di-isostearat, Neopentylglykoldicaprylat,
• – symmetrische, unsymmetrische oder cyclische Ester der Kohlensäure mit Fettalkoholen, beispielsweise beschrieben in der DE-OS 197 56 454 , Glycerincarbonat oder Dicaprylylcarbonat (Cetiol^® CC),
• – Trifettsäureester von gesättigten und/oder ungesättigten linearen und/oder verzweigten Fettsäuren mit Glycerin,
• – Fettsäurepartialglyceride, worunter Monoglyceride, Diglyceride und deren technische Gemische zu verstehen sind. Bei der Verwendung technischer Produkte können herstellungsbedingt noch geringe Mengen Triglyceride enthalten sein. Die Partialglyceride folgen vorzugsweise der Formel (D4-I),
  
  in der R¹, R² und R³ unabhängig voneinander für Wasserstoff oder für einen linearen oder verzweigten, gesättigten und/oder ungesättigten Acylrest mit 6 bis 22, vorzugsweise 12 bis 18, Kohlenstoffatomen stehen mit der Maßgabe, dass mindestens eine dieser Gruppen für einen Acylrest und mindestens eine dieser Gruppen für Wasserstoff steht. Die Summe (m + n + q) steht für 0 oder Zahlen von 1 bis 100, vorzugsweise für 0 oder 5 bis 25. Bevorzugt steht R¹ für einen Acylrest und R² und R³ für Wasserstoff und die Summe (m + n + q) ist 0. Typische Beispiele sind Mono- und/oder Diglyceride auf Basis von Capronsäure, Caprylsäure, 2-Ethylhexansäure, Caprinsäure, Laurinsäure, Isotridecansäure, Myristinsäure, Palmitinsäure, Palmoleinsäure, Stearinsäure, Isostearinsäure, Ölsäure, Elaidinsäure, Petroselinsäure, Linolsäure, Linolensäure, Elaeostearinsäure, Arachinsäure, Gadoleinsäure, Behensäure und Erucasäure sowie deren technische Mischungen. Vorzugsweise werden Ölsäuremonoglyceride eingesetzt.

The natural and synthetic cosmetic oil bodies include, for example:

• - vegetable oils. Examples of such oils are sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
• Liquid paraffin oils, isoparaffin oils and synthetic hydrocarbons and di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as, for example, di-n-octyl ether, di-n-decyl ether, di-n- nonyl ether, di-n-undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl n-undecyl ether and di-tert-bu tyl ether, di-iso-pentyl ether, di-3-ethyldecyl ether, tert-butyl-n-octyl ether, iso-pentyl-n-octyl ether and 2-methyl-pentyl-n-octyl ether. The compounds are available as commercial products 1,3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ^® S), and di-n-octyl ether (Cetiol ^® OE) may be preferred.
• - Ester oils. Ester oils are understood as meaning the esters of C ₆ -C ₃₀ -fatty acids with C ₂ -C ₃₀ -fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred. Examples of fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and Erucic acid and their technical mixtures, the z. As in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from the Roelen oxo synthesis or the dimerization of unsaturated fatty acids. Examples of the fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures, the z. B. incurred in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from the Roelen oxo synthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols. According to the invention, particularly preferred are isopropyl myristate (IPM Rilanit ^®), isononanoic acid C16-18 alkyl ester (Cetiol ^® SN), 2-ethylhexyl palmitate (Cegesoft ^® 24), stearic acid-2-ethylhexyl ester (Cetiol ^® 868), cetyl oleate, glycerol tricaprylate, Kokosfettalkoholcaprinat / caprylate (Cetiol ^® LC), n-butyl stearate, oleyl erucate (Cetiol ^® J 600), isopropyl palmitate (IPP Rilanit ^®), oleyl Oleate (Cetiol ^®), hexyl laurate (Cetiol ^® A), di-n-butyl adipate (Cetiol ^® B ), myristyl myristate (Cetiol ^® MM), Cetearyl Isononanoate (Cetiol ^® SN), decyl oleate (Cetiol ^® V).
• Dicarboxylic acid esters such as di-n-butyl adipate, di (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate, and diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2 ethylhexanoate), propylene glycol diisostearate, propylene glycol di-pelargonate, butanediol diisostearate, neopentyl glycol dicaprylate,
• Symmetrical, unsymmetrical or cyclic esters of carbonic acid with fatty alcohols, for example described in US Pat DE-OS 197 56 454 , Glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC),
• Triflic acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol,
• - fatty acid partial glycerides, which are understood to mean monoglycerides, diglycerides and their technical mixtures. With the use of technical products production reasons may still contain small amounts of triglycerides. The partial glycerides preferably follow the formula (D4-I),
  
  in which R ¹ , R ² and R ³ independently of one another represent hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, carbon atoms, with the proviso that at least one of these groups represents a Acyl radical and at least one of these groups is hydrogen. The sum (m + n + q) is 0 or numbers from 1 to 100, preferably 0 or 5 to 25. Preferably, R ^{1 is} an acyl radical and R ² and R ^{3 are} hydrogen and the sum (m + n + q) is 0. Typical examples are mono- and / or diglycerides based on caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic , Elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures. Preferably, oleic acid monoglycerides are used.

The Use of natural and synthetic cosmetic oil bodies in the inventive compositions preferably 0.1-30% by weight, based on the total application preparation, more preferably 0.1-20% by weight, and especially preferred 0.1-15% by weight.

Further suitable care substances are enzymes. Particularly according to the invention Preferred enzymes are selected from a group which is formed from proteases, lipases, transglutaminase, oxidases and peroxidases.

Also Pearl extracts are suitable as a conditioner.

beads shellfish are essentially inorganic and organic Calcium salts, trace elements and proteins. Pearls can be Easily gain from cultivated mussels. The cultivation The shells can be fresh in as well done in seawater. This can affect the ingredients of Impact beads. According to the invention is preferred a pearl extract, which cultured in marine or salt water Shells came. The pearls consist to a large extent from aragonite (calcium carbonate), conchiolin and an albuminoid. The latter components are proteins. Furthermore, in pearls are still Magnesium and sodium salts, inorganic silicon compounds as well Contain phosphates.

To prepare the pearl extract, the beads are pulverized. Thereafter, the pulverized beads are extracted by the usual methods. As extraction agent for the preparation of the pearl extracts, water, alcohols and mixtures thereof can be used. Underwater are understood to mean both demineralized water and seawater. Among the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as glycerol, diglycerol, triglycerol, polyglycerol, ethylene glycol, propylene glycol and butylene glycol, both as sole extractant and in admixture with demineralized water or sea water, preferably. Pearl extracts based on water / glycerine mixtures have proven to be particularly suitable. Depending on the extraction conditions, the pearl proteins (conchiloin and albuminoid) can be largely in the native state or already partially or largely present as protein hydrolysates. Preference is given to a pearl extract in which conchiolin and albuminoid are already partially hydrolyzed. The essential amino acids of these proteins are glutamic acid, serine, alanine, glycine, aspartic acid and phenylalanine. In a further particularly preferred embodiment, it may be advantageous if the pearl extract is additionally enriched with at least one or more of these amino acids. In the most preferred embodiment, the pearl extract is enriched with glutamic acid, serine and leucine. Furthermore, depending on the extraction conditions, in particular depending on the choice of extractant, a more or less large proportion of minerals and trace elements in the extract is found again. A preferred extract contains organic and / or inorganic calcium salts as well as magnesium and sodium salts, inorganic silicon compounds and / or phosphates. A most preferred pearl extract contains at least 75%, preferably 85%, more preferably 90% and most preferably 95% of all ingredients of the naturally occurring pearls. Examples of pearl extracts usable according to the invention are the commercial products Pearl Protein Extract BG ^® or Crodarom ^® Pearl.

The Bead extracts described above are preferably in an amount from at least 0.01 up to 20 wt .-%. To be favoured Quantities of the extract from 0.01 to 10 wt .-%, most preferably Amounts of 0.01 to 5 wt .-% based on the total two-component agent used.

Even though each of the aforementioned care substances already on its own A satisfactory result results are within the scope of the present Invention also includes all embodiments in which the agent contains several care substances also from different groups.

• – nichtionische Polymere wie beispielsweise Vinylpyrrolidinon/Vinylacrylat-Copolymere, Polyvinylpyrrolidinon und Vinylpyrrolidinon/Vinylacetat-Copolymere und Polysiloxane,
• – kationische Polymere wie quaternisierte Celluloseether, Polysiloxane mit quaternären Gruppen, Dimethyldiallylammoniumchlorid-Polymere, Acrylamid-Dimethyldiallyl-ammoniumchlorid-Copolymere, mit Diethylsulfat quaternierte Dimethylamino-ethylmethacrylat-Vinylpyrrolidinon-Copolymere, Vinylpyrrolidinon-Imidazolinium-methochlorid-Copolymere und quaternierter Polyvinylalkohol,
• – zwitterionische und amphotere Polymere wie beispielsweise Acrylamidopropyl-trimethylammoniumchlorid/Acrylat-Copolymere und Octylacrylamid/Methyl-methacrylat/tert-Butylaminoethylmethacrylat/2-Hydroxypropylmethacrylat-Copolymere,
• – anionische Polymere wie beispielsweise Polyacrylsäuren, vernetzte Polyacrylsäuren, Vinylacetat/Crotonsäure-Copolymere, Vinylpyrrolidinon/Vinylacrylat-Copolymere, Vinylacetat/Butylmaleat/Isobornylacrylat-Copolymere, Methylvinylether/Maleinsäureanhydrid-Copolymere und Acrylsäure/Ethylacrylat/N-tert-Butyl-acrylamid-Terpolymere,
• – Verdickungsmittel wie Agar-Agar, Guar-Gum, Alginate, Xanthan-Gum, Gummi arabicum, Karaya-Gummi, Johannisbrotkernmehl, Leinsamengummen, Dextrane, Cellulose-Derivate, z. B. Methylcellulose, Hydroxyalkylcellulose und Carboxymethylcellulose, Stärke-Fraktionen und Derivate wie Amylose, Amylopektin und Dextrine, Tone wie z. B. Bentonit oder vollsynthetische Hydrokolloide wie z. B. Polyvinylalkohol,
• – Strukturanten wie Glucose, Maleinsäure und Milchsäure,
• – haarkonditionierende Verbindungen wie Phospholipide, beispielsweise Sojalecithin, Ei-Lecitin und Kephaline sowie Silikonöle,
• – Proteinhydrolysate, insbesondere Elastin-, Kollagen-, Keratin-, Milcheiweiß-, Sojaprotein- und Weizenproteinhydrolysate, deren Kondensationsprodukte mit Fettsäuren sowie quaternisierte Proteinhydrolysate,
• – Parfümöle, Dimethylisosorbid und Cyclodextrine,
• – Lösungsmittel und -vermittler wie Ethanol, Isopropanol, Ethylenglykol, Propylenglykol, Glycerin und Diethylenglykol,
• – faserstrukturverbessernde Wirkstoffe, insbesondere Mono-, Di- und Oligosaccharide wie beispielsweise Glucose, Galactose, Fructose, Fruchtzucker und Lactose,
• – quaternierte Amine wie Methyl-1-alkylamidoethyl-2-alkylimidazolinium-methosulfat
• – Entschäumer wie Silikone,
• – Farbstoffe zum Anfärben des Mittels,
• – Antischuppenwirkstoffe wie Piroctone Olamine, Zink Omadine und Climbazol,
• – Lichtschutzmittel, insbesondere derivatisierte Benzophenone, Zimtsäure-Derivate und Triazine,
• – Substanzen zur Einstellung des pH-Wertes, wie beispielsweise übliche Säuren, insbesondere Genusssäuren und Basen,
• – Wirkstoffe wie Panthenol, Pantothensäure, Pantolacton, Allantoin, Pyrrolidinoncarbonsäuren und deren Salze sowie Bisabolol,
• – Vitamine, Provitamine und Vitaminvorstufen, insbesondere solche der Gruppen A, B₃, B₅, B₆, C, E, F und H,
• – Pflanzenextrakte wie die Extrakte aus Grünem Tee, Eichenrinde, Brennnessel, Hamamelis, Hopfen, Kamille, Klettenwurzel, Schachtelhalm, Weißdorn, Lindenblüten, Mandel, Aloe Vera, Fichtennadel, Rosskastanie, Sandelholz, Wacholder, Kokosnuss, Mango, Aprikose, Limone, Weizen, Kiwi, Melone, Orange, Grapefruit, Salbei, Rosmarin, Birke, Malve, Wiesenschaumkraut, Quendel, Schafgarbe, Thymian, Melisse, Hauhechel, Huflattich, Eibisch, Meristem, Ginseng und Ingwerwurzel,
• – Cholesterin,
• – Konsistenzgeber wie Zuckerester, Polyolester oder Polyolalkylether,
• – Fette und Wachse wie Walrat, Bienenwachs, Montanwachs und Paraffine,
• – Fettsäurealkanolamide,
• – Komplexbildner wie EDTA, NTA, β-Alanindiessigsäure und Phosphonsäuren,
• – Quell- und Penetrationsstoffe wie Glycerin, Propylenglykolmonoethylether, Carbonate, Hydrogencarbonate, Guanidine, Harnstoffe sowie primäre, sekundäre und tertiäre Phosphate,
• – Trübungsmittel wie Latex, Styrol/PVP- und Styrol/Acrylamid-Copolymere
• – Perlglanzmittel wie Ethylenglykolmono- und -distearat sowie PEG-3-distearat,
• – Pigmente,
• – Stabilisierungsmittel für Wasserstoffperoxid und andere Oxidationsmittel,
• – Treibmittel wie Propan-Butan-Gemische, N₂O, Dimethylether, CO₂ und Luft,
• – Antioxidantien.

Furthermore, the agents according to the invention may contain other active ingredients, auxiliaries and additives, such as, for example

• Nonionic polymers such as vinylpyrrolidinone / vinyl acrylate copolymers, polyvinylpyrrolidinone and vinylpyrrolidinone / vinyl acetate copolymers and polysiloxanes,
• Cationic polymers such as quaternized cellulose ethers, quaternary group polysiloxanes, dimethyldiallylammonium chloride polymers, acrylamide-dimethyldiallyl-ammonium chloride copolymers, diethyl sulfate quaternized dimethylaminoethylmethacrylate-vinylpyrrolidinone copolymers, vinylpyrrolidinone-imidazolinium methochloride copolymers and quaternized polyvinyl alcohol,
• Zwitterionic and amphoteric polymers such as, for example, acrylamidopropyltrimethylammonium chloride / acrylate copolymers and octylacrylamide / methyl methacrylate / tert-butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers,
• Anionic polymers, for example polyacrylic acids, crosslinked polyacrylic acids, vinyl acetate / crotonic acid copolymers, vinylpyrrolidinone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobornyl acrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and acrylic acid / ethyl acrylate / N-tert-butylacrylamide terpolymers,
• Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. Methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose, starch fractions and derivatives such as amylose, amylopectin and Dextrins, clays such. As bentonite or fully synthetic hydrocolloids such. For example, polyvinyl alcohol,
• - structurants such as glucose, maleic acid and lactic acid,
• Hair-conditioning compounds such as phospholipids, for example soybean lecithin, egg lecithin and cephalins and silicone oils,
• Protein hydrolysates, in particular elastin, collagen, keratin, milk protein, soy protein and wheat protein hydrolysates, their condensation products with fatty acids and quaternized protein hydrolysates,
• Perfume oils, dimethylisosorbide and cyclodextrins,
• Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol,
• Fiber-structure-improving active substances, in particular mono-, di- and oligosaccharides such as, for example, glucose, galactose, fructose, fructose and lactose,
• Quaternized amines such as methyl-1-alkylamidoethyl-2-alkylimidazolinium methosulfate
• Defoamers like silicones,
• Dyes for staining the agent,
• Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
• - light stabilizers, in particular derivatized benzophenones, cinnamic acid derivatives and triazines,
• Substances for adjusting the pH, for example customary acids, in particular edible acids and bases,
• - active substances such as panthenol, pantothenic acid, pantolactone, allantoin, pyrrolidinonecarboxylic acids and their salts, and bisabolol,
• Vitamins, provitamins and vitamin precursors, in particular those of groups A, B ₃ , B ₅ , B ₆ , C, E, F and H,
• - Plant extracts such as extracts of green tea, oak bark, nettle, witch hazel, hops, chamomile, burdock root, horsetail, hawthorn, linden, almond, aloe vera, spruce needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot, lime, wheat, Kiwi, melon, orange, grapefruit, sage, rosemary, birch, mallow, meadowfoam, quenelle, yarrow, thyme, melissa, toadstool, coltsfoot, marshmallow, meristem, ginseng and ginger root,
• - cholesterol,
• Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers,
• - fats and waxes such as spermaceti, beeswax, montan wax and paraffins,
• Fatty acid alkanolamides,
• Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,
• - swelling and penetrating substances such as glycerol, propylene glycol monoethyl ether, carbonates, bicarbonates, guanidines, ureas and primary, secondary and tertiary phosphates,
• Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
• Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
• - pigments,
• Stabilizing agent for hydrogen peroxide and other oxidizing agents,
• Propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air,
• - antioxidants.

The Selection of these other substances will be apparent to those skilled in the art according to desired properties of the agents meet.

With regard to further optional components and the amounts of these components used, reference is expressly made to the relevant manuals known to the person skilled in the art, eg. B. Kh. Schrader, bases and formulations of the cosmetics, 2nd edition, Hüthig book publishing house, Heidelberg, 1989 , referenced.

The agents according to the invention containing the active ingredients usually in a cosmetic carrier. This cosmetic Carrier is preferably aqueous, alcoholic or aqueous-alcoholic. For the purpose of hair bleaching are such Carriers such as creams, emulsions, gels or else surfactant-containing foaming solutions, such as Shampoos, foam aerosols or other preparations intended for the application on the hair are suitable. But it is also possible for storage a powdery or tablet-shaped To provide formulation which is preferred for lightening agents is. This is then before use in a solvent, such as water or with organic solvents or with mixtures from water and organic solvents to obtain the Mixing application mixture.

One aqueous carrier contains in the sense of Invention at least 40% by weight, in particular at least 50% by weight Water.

For the purposes of the present invention, aqueous-alcoholic carriers are to be understood as meaning water-containing compositions containing from 3 to 70% by weight of a C ₁ -C ₄ -alcohol, in particular ethanol or isopropanol. The compositions according to the invention may additionally contain other organic solvents, such as, for example, methoxybutanol, ethyldiglycol, 1,2-propylene glycol, n-propanol, n-butanol, n-butylene glycol, glycerol, diethylene glycol monoethyl ether, and diethylene glycol mono-n-butyl ether. Preference is given to all water-soluble organic solvents.

preferred Means according to the invention are characterized that they additionally contain a nonaqueous solvent contain, with particularly preferred inventive Means the solvent in a concentration of 0.1 up to 30% by weight, preferably in a concentration of 1 to 20% by weight, most preferably in a concentration of 2 to 10 wt .-%, each based on the agent included.

One second subject of the present invention is a method for lightening keratin fibers, in particular human hair, wherein a means of the first subject of the invention to the keratin-containing Fibers applied, leave on the fiber for 5 to 60 minutes and then rinsed out again or with a Shampoo is washed out.

Especially the temperature during the exposure time is from 5 to 60 minutes between 10 ° C and 40 ° C, in particular between 20 ° C and 38 ° C.

• • gewünschtenfalls ein Vorbehandlungsmittel M1 auf die Faser aufgebracht wird, dann
• • ein Mittel M2 auf der Faser zur Anwendung kommt, wobei gewünschtenfalls dem Mittel M2 vor der Anwendung ein weiteres Mittel M3 zugegeben wird,
• • dieses Mittel M2 nach einer Zeit von 5 bis 60 Minuten von der Faser abgespült wird
• • und nach der Behandlung gegebenenfalls ein Nachbehandlungsmittel M4 auf die Faser aufgetragen und nach einer Einwirkzeit von einigen Minuten wieder abgespült wird,

wobei mindestens eines der Mittel M1, M2 oder M3 oder die Mischung der Mittel M2 und M3 ein erfindungsgemäßes Mittel des ersten Erfindungsgegenstandes ist.In the context of such a method it may be preferred that

• If desired, a pretreatment agent M1 is applied to the fiber, then
• A means M2 is applied to the fiber, wherein, if desired, an additional agent M3 is added to the agent M2 before use,
• • This agent M2 is rinsed off the fiber after 5 to 60 minutes
• • and after treatment, if necessary, apply M4 aftertreatment agent to the fiber and rinse again after a reaction time of a few minutes,

wherein at least one of the means M1, M2 or M3 or the mixture of the means M2 and M3 is an inventive means of the first subject of the invention.

One third object of the invention is the use of the means of first subject of the invention for lightening keratinhaltigen Fibers, in particular human hair.

In terms of further preferred embodiments of the invention Process or the use according to the invention applies mutatis mutandis to the invention Means said.

QUOTES INCLUDE IN THE DESCRIPTION

This list The documents listed by the applicant have been automated generated and is solely for better information recorded by the reader. The list is not part of the German Patent or utility model application. The DPMA takes over no liability for any errors or omissions.

Cited patent literature

• - DE 4413686 [0118, 0121]
• - DE 3929973 A [0125]
• WO 92/13829 [0130]
• - US 3753968 A [0151]
• DE 19756454A [0177]

Cited non-patent literature

• - Kh. Schrader, Basics and Formulations of Cosmetics, 2nd edition, 1989, Dr. med. Alfred Hüthig Verlag, Heidelberg [0002]
• - W. Umbach (ed.), Cosmetics, 2nd edition, 1995, Georg Thieme Verlag, Stuttgart, New York [0002]
• "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, Suite 300, Washington, DC 20036-4702) [0072]
• "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, Suite 300, Washington, DC 20036-4702) [0072]
• - "Encyclopedia of Polymer Science and Engineering, Volume 15, Second Edition, pp. 204-308 , John Wiley & Sons, Inc. 1989 [0094]
• "International Cosmetic Ingredient Dictionary and Handbook," (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, Suite 300, Washington, DC 20036-4702) [0122]
• - Kh. Schrader, bases and formulations of cosmetics, 2nd edition, Hüthig Buch Verlag, Heidelberg, 1989 [0187]

Claims (13)

Composition for lightening keratinic fibers obtained by mixing before use from two separately packaged preparations A) and B), wherein preparation A) contains hydrogen peroxide and preparation B) is free of hydrogen peroxide, characterized in that at least one of the preparations A) and B) contains at least one indicator which undergoes a color change upon mixing of the preparations. Means according to claim 1, characterized in that the preparations A) and B) have different pH values and a pH indicator is used as indicator. Means according to claim 2, characterized in that the pH indicator is selected from α-naphtholphthalein, Thymol blue, p-xylenol blue, o-cresolphthalein, phenolphthalein and Thymolphthalein. Means according to claim 3, characterized in that the pH indicator is contained in preparation A) and this one pH of 4 to 7.5. Means according to claim 1, characterized in that as indicator a redox indicator is used. Means according to claim 5, characterized in that the redox indicator is selected from neutral red, methylene blue and ferroin. Means according to claim 1, characterized in that it selected as an indicator at least one pH indicator from α-naphtholphthalein, thymol blue, p-xylenol blue, o-cresolphthalein, Phenolphthalein and thymolphthalein, and at least one redox indicator, selected from neutral red, methylene blue and ferroin. Means according to claim 7, characterized in that Preparation A) the pH indicator or the pH indicators and preparation B) contains the redox indicator or the redox indicators. Agent according to one of claims 1 to 8, characterized in that preparation A) is a aqueous hydrogen peroxide solution is. Agent according to one of claims 1 to 9, characterized in that it is a preparation B) Cream or gel, with the cream or gel in one cosmetically acceptable carrier at least one alkalizing agent and at least one nourishing substance. Agent according to one of claims 1 to 10, characterized in that it has a pH of 7 to 11. Method for whitening keratinic fibers, characterized characterized in that an agent according to one of the claims 1 to 11 applied to the fibers, 5 to 60 minutes on the fibers leave and then rinsed out again or washed out with a shampoo. Cosmetic use of an agent after one of claims 1 to 11 for lightening keratinic fibers, especially human hair.